NZ623962B2 - Methods of manufacturing plastic materials from decolorized blood protein - Google Patents
Methods of manufacturing plastic materials from decolorized blood protein Download PDFInfo
- Publication number
- NZ623962B2 NZ623962B2 NZ623962A NZ62396212A NZ623962B2 NZ 623962 B2 NZ623962 B2 NZ 623962B2 NZ 623962 A NZ623962 A NZ 623962A NZ 62396212 A NZ62396212 A NZ 62396212A NZ 623962 B2 NZ623962 B2 NZ 623962B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- blood
- plasticizer
- plastic material
- blood protein
- protein
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 147
- 229920003023 plastic Polymers 0.000 title claims abstract description 136
- 239000004033 plastic Substances 0.000 title claims abstract description 136
- 102000004506 Blood Proteins Human genes 0.000 title claims abstract description 103
- 108010017384 Blood Proteins Proteins 0.000 title claims abstract description 103
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 129
- 239000004014 plasticizer Substances 0.000 claims abstract description 77
- 239000007800 oxidant agent Substances 0.000 claims abstract description 63
- KFSLWBXXFJQRDL-UHFFFAOYSA-N peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 350
- 239000005996 Blood meal Substances 0.000 claims description 142
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 93
- GEHJYWRUCIMESM-UHFFFAOYSA-L Sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 84
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 74
- 239000003795 chemical substances by application Substances 0.000 claims description 73
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 72
- 210000004369 Blood Anatomy 0.000 claims description 63
- 239000008280 blood Substances 0.000 claims description 63
- 108010054147 Hemoglobins Proteins 0.000 claims description 57
- 102000001554 Hemoglobins Human genes 0.000 claims description 57
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 52
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 210000003743 Erythrocytes Anatomy 0.000 claims description 46
- 210000003324 RBC Anatomy 0.000 claims description 46
- 235000010265 sodium sulphite Nutrition 0.000 claims description 42
- 239000000654 additive Substances 0.000 claims description 39
- 239000000243 solution Substances 0.000 claims description 39
- 239000007921 spray Substances 0.000 claims description 39
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N Triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 37
- MTHSVFCYNBDYFN-UHFFFAOYSA-N Diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 36
- 239000004927 clay Substances 0.000 claims description 34
- 229910052570 clay Inorganic materials 0.000 claims description 34
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (-)-propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 31
- 229960004063 Propylene glycol Drugs 0.000 claims description 31
- 235000013772 propylene glycol Nutrition 0.000 claims description 31
- 239000007864 aqueous solution Substances 0.000 claims description 24
- UKLNMMHNWFDKNT-UHFFFAOYSA-M Sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 claims description 22
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 22
- 229960002218 sodium chlorite Drugs 0.000 claims description 22
- 239000004115 Sodium Silicate Substances 0.000 claims description 14
- NTHWMYGWWRZVTN-UHFFFAOYSA-N Sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 14
- 239000004328 sodium tetraborate Substances 0.000 claims description 14
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims description 13
- 230000000996 additive Effects 0.000 claims description 13
- URAYPUMNDPQOKB-UHFFFAOYSA-N Triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 11
- 229960002622 Triacetin Drugs 0.000 claims description 11
- 239000001087 glyceryl triacetate Substances 0.000 claims description 11
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 11
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 10
- 235000012424 soybean oil Nutrition 0.000 claims description 10
- 239000003549 soybean oil Substances 0.000 claims description 10
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N tributyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 claims description 10
- 239000001069 triethyl citrate Substances 0.000 claims description 10
- 235000013769 triethyl citrate Nutrition 0.000 claims description 10
- 229940080314 Sodium Bentonite Drugs 0.000 claims description 9
- ONCZQWJXONKSMM-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4].[Si+4].[Si+4].[Si+4] ONCZQWJXONKSMM-UHFFFAOYSA-N 0.000 claims description 9
- 229910000280 sodium bentonite Inorganic materials 0.000 claims description 9
- 150000001412 amines Chemical class 0.000 claims description 6
- 210000002966 Serum Anatomy 0.000 claims description 4
- 230000003226 decolorizating Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 description 178
- 108090000623 proteins and genes Proteins 0.000 description 177
- 235000018102 proteins Nutrition 0.000 description 176
- 230000003993 interaction Effects 0.000 description 35
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- 239000000047 product Substances 0.000 description 24
- 230000035943 smell Effects 0.000 description 24
- 238000001125 extrusion Methods 0.000 description 22
- 235000011187 glycerol Nutrition 0.000 description 21
- 238000004042 decolorization Methods 0.000 description 20
- 150000003278 haem Chemical group 0.000 description 19
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 238000005755 formation reaction Methods 0.000 description 17
- 238000002156 mixing Methods 0.000 description 17
- 229920000642 polymer Polymers 0.000 description 17
- 229920001169 thermoplastic Polymers 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 16
- 239000004202 carbamide Substances 0.000 description 15
- 239000007795 chemical reaction product Substances 0.000 description 15
- 238000007792 addition Methods 0.000 description 14
- 238000001746 injection moulding Methods 0.000 description 14
- 239000004416 thermosoftening plastic Substances 0.000 description 14
- 229940092782 Bentonite Drugs 0.000 description 13
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 13
- 238000002441 X-ray diffraction Methods 0.000 description 13
- 229910000278 bentonite Inorganic materials 0.000 description 13
- 239000000440 bentonite Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 235000019624 protein content Nutrition 0.000 description 12
- 239000000853 adhesive Substances 0.000 description 11
- 230000001070 adhesive Effects 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 238000004132 cross linking Methods 0.000 description 11
- 230000000670 limiting Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 10
- 238000007906 compression Methods 0.000 description 10
- 238000000059 patterning Methods 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 235000010469 Glycine max Nutrition 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 235000013372 meat Nutrition 0.000 description 9
- 239000002699 waste material Substances 0.000 description 9
- 241000283690 Bos taurus Species 0.000 description 8
- 230000003466 anti-cipated Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000002829 reduced Effects 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 229920001187 thermosetting polymer Polymers 0.000 description 8
- 238000010306 acid treatment Methods 0.000 description 7
- 238000000748 compression moulding Methods 0.000 description 7
- 238000004332 deodorization Methods 0.000 description 7
- 102000018146 globin family Human genes 0.000 description 7
- 108060003196 globin family Proteins 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- IMSOBGJSYSFTKG-PKPIPKONSA-N (2S)-2-amino-6-[(2-amino-2-carboxyethyl)amino]hexanoic acid Chemical compound OC(=O)[C@@H](N)CCCCNCC(N)C(O)=O IMSOBGJSYSFTKG-PKPIPKONSA-N 0.000 description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- NHYCGSASNAIGLD-UHFFFAOYSA-N chlorine monoxide Inorganic materials Cl[O] NHYCGSASNAIGLD-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 102000036752 TRIM/RBCC family Human genes 0.000 description 5
- 108091007086 TRIM/RBCC family Proteins 0.000 description 5
- 229920000704 biodegradable plastic Polymers 0.000 description 5
- 235000018417 cysteine Nutrition 0.000 description 5
- 230000003247 decreasing Effects 0.000 description 5
- 150000002019 disulfides Chemical class 0.000 description 5
- 239000012467 final product Substances 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 230000002209 hydrophobic Effects 0.000 description 5
- -1 polyethylene Polymers 0.000 description 5
- 230000004850 protein–protein interaction Effects 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 229940105657 CATALASE Drugs 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 102000016938 EC 1.11.1.6 Human genes 0.000 description 4
- 108010053835 EC 1.11.1.6 Proteins 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 241000283898 Ovis Species 0.000 description 4
- XXQBEVHPUKOQEO-UHFFFAOYSA-N Potassium superoxide Chemical compound [K+].[K+].[O-][O-] XXQBEVHPUKOQEO-UHFFFAOYSA-N 0.000 description 4
- 229940001941 Soy Proteins Drugs 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000009830 intercalation Methods 0.000 description 4
- 230000002687 intercalation Effects 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000006011 modification reaction Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- 239000012460 protein solution Substances 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 108091005771 Peptidases Proteins 0.000 description 3
- 102000035443 Peptidases Human genes 0.000 description 3
- 108010078762 Protein Precursors Proteins 0.000 description 3
- 102000014961 Protein Precursors Human genes 0.000 description 3
- 241000209149 Zea Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000002378 acidificating Effects 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004027 cells Anatomy 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 235000005824 corn Nutrition 0.000 description 3
- 239000003398 denaturant Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 230000002427 irreversible Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 230000003472 neutralizing Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000002335 preservative Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N silicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 3
- 239000004634 thermosetting polymer Substances 0.000 description 3
- 230000002588 toxic Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- UQBOJOOOTLPNST-UHFFFAOYSA-N 2-aminoprop-2-enoic acid Chemical compound NC(=C)C(O)=O UQBOJOOOTLPNST-UHFFFAOYSA-N 0.000 description 2
- LHJQIRIGXXHNLA-UHFFFAOYSA-N Calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 2
- 239000004343 Calcium peroxide Substances 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 229960003067 Cystine Drugs 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N DL-lysine Chemical group NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 210000002381 Plasma Anatomy 0.000 description 2
- 239000004698 Polyethylene (PE) Substances 0.000 description 2
- 229940024999 Proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 229940005550 Sodium alginate Drugs 0.000 description 2
- PFUVRDFDKPNGAV-UHFFFAOYSA-N Sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003078 antioxidant Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- 235000019402 calcium peroxide Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000001143 conditioned Effects 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000011068 load Methods 0.000 description 2
- 239000000289 melt material Substances 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 150000002823 nitrates Chemical class 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 239000003638 reducing agent Substances 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- MSXHSNHNTORCAW-UHFFFAOYSA-M sodium 3,4,5,6-tetrahydroxyoxane-2-carboxylate Chemical compound [Na+].OC1OC(C([O-])=O)C(O)C(O)C1O MSXHSNHNTORCAW-UHFFFAOYSA-M 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000009864 tensile test Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 102100001249 ALB Human genes 0.000 description 1
- 101710027066 ALB Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000219430 Betula pendula Species 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 229940112822 Chewing Gum Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L Copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
- 229940088598 Enzyme Drugs 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 210000003746 Feathers Anatomy 0.000 description 1
- 229940012952 Fibrinogen Drugs 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 229940019698 Fibrinogen containing hemostatics Drugs 0.000 description 1
- 229940084428 Freezone Drugs 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 229960000789 Guanidine Hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N Guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 102100019126 HBB Human genes 0.000 description 1
- 108091005902 Hemoglobin subunit beta Proteins 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 210000003739 Neck Anatomy 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229940055729 Papain Drugs 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- RKCAIXNGYQCCAL-UHFFFAOYSA-N Porphin Chemical compound N1C(C=C2N=C(C=C3NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 RKCAIXNGYQCCAL-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- YZHUMGUJCQRKBT-UHFFFAOYSA-M Sodium chlorate Chemical compound [Na+].[O-]Cl(=O)=O YZHUMGUJCQRKBT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 229940093612 Zein Drugs 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- SSBRSHIQIANGKS-UHFFFAOYSA-N [amino(hydroxy)methylidene]azanium;hydrogen sulfate Chemical compound NC(N)=O.OS(O)(=O)=O SSBRSHIQIANGKS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000000274 adsorptive Effects 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 231100000693 bioaccumulation Toxicity 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000002354 carica papaya Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000003508 chemical denaturation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-M chlorite Chemical compound [O-]Cl=O QBWCMBCROVPCKQ-UHFFFAOYSA-M 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000004059 degradation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 102000034327 globular proteins Human genes 0.000 description 1
- 108091005889 globular proteins Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 108010036302 hemoglobin AS Proteins 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000010102 injection blow moulding Methods 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 108091005569 modified proteins Proteins 0.000 description 1
- 102000035365 modified proteins Human genes 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 238000010137 moulding (plastic) Methods 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- 239000005445 natural product Substances 0.000 description 1
- 229930014626 natural products Natural products 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 238000001175 rotational moulding Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229940080281 sodium chlorate Drugs 0.000 description 1
- AWLUSOLTCFEHNE-UHFFFAOYSA-N sodium;urea Chemical compound [Na].NC(N)=O AWLUSOLTCFEHNE-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000009283 thermal hydrolysis Methods 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
Abstract
Disclosed is a method of decolourising blood protein and manufacturing the decolourised blood protein into a plastic material, the method comprising: -contacting the blood protein with an oxidising agent to form a blood protein composition that includes unreacted oxidizing agent; -removing at least a portion of the unreacted oxidising agent from the blood protein composition to form a decolourised blood protein composition; and -treating the decolourised blood protein composition in the presence of a plasticiser with sufficient pressure and temperature to form the plastic material. Also disclosed is a plastic material, comprising: -a blood protein residue having a percent whiteness of 35%-100%; and -a plasticiser. t a portion of the unreacted oxidising agent from the blood protein composition to form a decolourised blood protein composition; and -treating the decolourised blood protein composition in the presence of a plasticiser with sufficient pressure and temperature to form the plastic material. Also disclosed is a plastic material, comprising: -a blood protein residue having a percent whiteness of 35%-100%; and -a plasticiser.
Description
James & Wells Ref: 134352NZ/47
METHODS OF MANUFACTURING PLASTIC MATERIALS FROM DECOLORIZED
BLOOD PROTEIN
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Application No. 61/566,520,
filed on December 2, 2011, the disclosure of which is hereby incorporated by reference in its
entirety.
BACKGROUND
1. Field
The present disclosure relates generally to methods of manufacturing plastic
materials, and more specifically to methods of manufacturing plastic materials from decolorized
blood protein. The present disclosure also provides a plastic material including a blood protein
residue having a percent whiteness of 35%-100% and a plasticizer.
2. Description of Related Art
Modern plastics are typically produced from petrochemical sources. Plastics are
generally made up of polymers, including long chains of repeating molecular units, or
monomers. The vast majority of plastics are composed of polymers of carbon alone, or carbon in
combination with oxygen, nitrogen, chlorine or sulfur in the backbone. The properties of the
polymer can be altered by introducing different functional groups into or onto the polymer
backbone.
The history of plastic materials originated with the development of natural materials
such as chewing gum and shellac. These materials however, require prohibitively expensive and
intensive methods to isolate and manipulate the natural product. Later developments included
the use of chemically modified natural materials such as rubber and nitrocellulose, and later to
the use of manmade molecules such as epoxy, polyvinylchloride and polyethylene. The
development of manmade plastic molecules has led to a staggering worldwide increase in the use
of plastics, for wide ranging purposes, including packaging, technology such as computers, cell
phones and many household appliances. Plastic is cheap and easy to manufacture.
James & Wells Ref: 134352NZ/47
The main characteristic of polymers that allows it to be so widely used is that some
polymers can be thermoplastic (or plastic) and others can be thermosetting. Thermoplastic
materials are deformable, they melt to a liquid when heated to a sufficient temperature and
solidify into a solid state when cooled. Most thermoplastics are high molecular weight polymers
whose chains associate through weak Van der Waals forces, for example in polyethylene;
stronger dipole interactions and hydrogen bonding, for example in nylon; or stacking of aromatic
rings, for example in polystyrene. Thermoplastic polymers differ from thermosetting polymers.
Whereas thermoplastic polymers can be repeatedly melted and cooled, thermosetting polymers,
once formed and cured will not re-melt to allow re-molding or re-use of the material.
Thermoplastic or thermosetting polymers can be formed into a desired shape by injection into
molds while in their liquid or fluid state and when cooled the shape of the mold is retained. In
this way they can be easily be used to make a wide variety of complex shapes.
The manufacture of thermoplastics from petrochemical sources utilizes the following
general method: 1) drilling and transporting petroleum to a refinery; 2) refining crude oil and
natural gas into ethane, propane and other petrochemical products; 3) cracking ethane and
propane into ethylene and propylene using high temperature furnaces; 4) the addition of a
catalyst to ethylene or propylene in a reactor, resulting in a powdered polymer; 5) combining the
powdered polymer with additives (if required) in a continuous blender; 6) feeding the polymer
into an extruder where it is melted; 7) cooling the melted plastic which is then feed into a
pulverizer that cuts the cooled plastic into small pellets; 8) shipping the pellets to customers; and
9) manufacturing plastic products from the pellets by various methods, including extrusion,
injection molding, blow molding and rotational molding.
While the use of petrochemical sources to produce plastics is ongoing, it has a
number of significant disadvantages, both to the environment and society. The first disadvantage
is that plastics degrade very slowly. This leads to a high accumulation of unwanted and
untreatable waste. While methods are being developed to increase the breakdown rate of
plastics, such as the incorporation of biodegradable plastics or natural materials, such as starch is
increasing, this in no way matches the worldwide consumption and subsequent disposal of
plastic items. The high waste accumulation can also be off-set by recycling. However, recycling
of plastics is not easy, and again includes a number of significant disadvantages. For example, it
James & Wells Ref: 134352NZ/47
is difficult to automate the sorting of plastic wastes into plastic type or color, and the use of
manual sorting is very labor intensive. An additional complicating factor is that while many
plastic containers are made from a single type and color of plastic, which are relatively easy to
sort, many other products such as cell phones often include many small parts of different types
and colors of plastics. In these situations, the time and resources required to separate the plastics
for recycling far exceed their recycling value.
A second significant disadvantage of standard plastic material is their effect on the
environment. Plastics have a long breakdown time and can harm wildlife. For example, the
plastic rings which hold 6-packs of cans can easily get around the necks birds and other wildlife
and can strangle them. The increase of plastic waste in oceans may also lead to the transport of
small species from country to country, or continent to continent. This may lead to the
introduction of invasive or unwanted pests into new areas. Similarly, burning plastic material
can in some cases release toxic fumes which can be harmful to those working or living in the
area. Also, the manufacturing of plastics can often lead to large quantities of chemical
pollutants.
A third significant disadvantage of petrochemical plastics is that petroleum resources
are naturally limited. Therefore, in the future this is likely to lead to increased cost and
decreased desirability of using these compounds on the current scale.
The problems with using petroleum based precursors in the manufacture of adhesives
have been addressed by the development of a number of protein or soy protein based adhesives.
Proteins are natural biopolymers. The amino acids found in proteins offer many chemical
interactions, due to the different functional side chains. Hydrogen bonds, ionic interactions,
hydrophobic interactions and covalent disulfide bonds between these side chains give a protein
its native structure. Proteins are versatile materials; the properties depend on the amino acid
content and the modifications that are performed to improve specific properties. Reactive amino
acids in proteins include the following: amide (15-40%), acidic (2-10%), neutral (6-10%), basic
(13- 20%), and sulfur containing (0-3%) (De Graaf and Kolster, 1998).
In the materials industry these different side chains of proteins can be manipulated
and used to add cross-linkers giving the material produced new mechanical properties. The
James & Wells Ref: 134352NZ/47
processing of adhesives, films, coatings, or other protein based materials requires the breaking of
intermolecular bonds (covalent and non- covalent), arranging the free protein chains into the
desired shape, and then allowing the formation of new intermolecular bonds and interactions to
stabilize the three dimensional structure. Cysteine, a sulfur containing amino acid, is found to be
involved in non-disulfide irreversible covalent cross-linking (lysinoalanine and others) when
proteins are placed under high temperature, which can become problematic in processing
(Barone and Dangaran et al, 2006; Barone and Schmidt et al, 2006; De Graaf, 2000; Marion
Pommet, 2003 and Singh, 1991). Lysinoalanine is an unnatural covalent crosslink that occurs
through the formation of dehydroalanine and reactive lysl residues, in alkaline and heated
systems. Cystine disulfide bonds form dehydroresidues in alkaline conditions, which are the
reactive precursors for lysinoalanine. These non-disulfide covalent crosslinks once formed do
not melt or exchange at high temperatures (Mohammed et al, 2000). Their formation in a high
protein system can prevent a flowable melt material forming.
The major disadvantage of using protein based sources in the manufacture of
adhesives is that they lack adhesive strength and water resistance. This issue has been addressed
by using modified proteins such as soy, for example as described in WO 00/08110 which
describes a method of using modified soy protein to provide a stronger and more water resistant
adhesive. In the soy based adhesives described in WO 00/08110, the protein molecules are
dispersed, and thus partially unfolded in dispersion. The unfolded molecules increase the contact
area in adhesion of protein molecules onto other surfaces. The unfolded nature of the molecules
also allows them to entangle each other during the curing process to provide additional bonding
strength. Soy based adhesives overcome some of the problems associated with petroleum based
products; they make use of soy proteins which are environmentally friendly and more sustainable
than petroleum resources.
The soy proteins in WO 00/08110 are modified with one or more modifiers,
including, for example urea, guanidine hydrochloride, SDS (Sodium Dodecyl Sulfate), and
SDBS (Sodium Dodecylbenzene Sulfonate) or a mixture of these. The method disclosed
involves mixing the modifiers, water and soy protein to form a slurry or dispersion. The
modifiers act to unravel the proteins. After mixing, the reacted dispersion can be immediately
used as an adhesive, or can be freeze dried, milled into a powder and stored for later use after
James & Wells Ref: 134352NZ/47
being reconstituted. WO 00/08110 discloses reaction temperatures from 10 to 80°C under which
the mixing is carried out; however, preferably the mixing process is undertaken at ambient
temperature and pressure conditions.
Bovine blood has previously been used as an adhesive. The main use of this was in
the manufacture of particle board (Francis, 2000).
One disadvantage of using protein polymers which decreases their usability, is that
they lack the mechanical properties of petrochemically derived polymers—this gives them
unpredictable processing characteristics. A further significant disadvantage of protein polymers
is the price. Protein polymers are significantly more expensive than commodity petro-
chemically derived polymers. This increased cost has in the past been sufficient to prohibit
mainstream use of protein polymers in adhesives.
The use of soy protein for the manufacture of plastic materials, given the high volume
requirement for precursor material, places a strain on the supply source. This may decrease the
amount of soy for food based products. Soy proteins also have the same disadvantages
mentioned for protein polymers above, mainly the lack of mechanical properties and high price.
Extrusion work on proteins has previously been undertaken for zein and soy proteins. These
were plasticized with oleic acid, glycerol or water. Extensive research has also been undertaken
on corn gluten meal (mixture of various proteins found in corn). It was found that various
additives were necessary to plasticize these proteins, and that the material had inferior strength
compared to petrochemical equivalents.
It would therefore be desirable to provide plastic materials, and methods of producing
same from a high volume, low cost, sustainable and renewable protein source with sufficient
mechanical properties. WO08/063088 describes producing plastic materials from a protein
source, including blood. However, improvements in the color and smell of blood-protein plastic
materials are desirable if such plastics are to be used in a range of applications. Preferably,
methods to decolor and/or deodor blood-protein plastic materials will maintain the molecular
weight of the blood protein allowing it to maintain its ability to be processed into a plastic
material.
James & Wells Ref: 134352NZ/47
Hemoglobin is a globular protein used to bind and transport oxygen in blood. Its
molecular mass is approximately 64.45 kDa and contains two α and two β globin protein chains.
Each α chain has 141 amino acids and each β chain has 146. All vertebrate hemoglobins are
similar in structure and composition. Each globin chain has an iron containing heme group non-
covalently bonded to it. The heme group is responsible for the color of the blood protein. To
remove the color, the heme group must be removed or degraded.
Heme adsorption using organic solvents or adsorptive media has been used to
produce decolorized hemoglobin. However, such reagents must be used in large quantities and
are expensive, limiting their large scale application. Hemoglobin may be treated with proteolytic
enzymes to produce peptides, but this method requires several processing steps. Hydrogen
peroxide may be used as a less expensive alternative to decolor hemoglobin.
Heme is bound to the globin chain by non-covalent bonds. Treatment of hemoglobin
at low pH (pH 2-5) causes the heme group to dissociate from the globin. Dissociated heme can
be separated from the globin using organic solvents. Cold acidified acetone is the most efficient
and most often used, but methylethyketone (MEK), methanol and ethanol have also been used.
Tybor et al (1973) decolorized hemoglobin by adjusting to pH 4 using ascorbic acid prior to
treatment with acidified acetone. This method required large volumes of acetone (4 liters of
acetone per 1 liter of protein solution). This method has not been used on a large scale because
acetone is toxic and it is difficult to remove residues from the final product. In addition, acetone
is a volatile organic solvent; therefore, processing facilities need to be designed to contain it.
Adsorption media such as activated carbon or carboxymethyl cellulose (CMC) can be
used as an alternative to organic solvents to remove the heme from acidified hemoglobin
solutions. Sato et al (1981) used CMC chromatography to remove dissociated heme. However
this method required low protein loading rates (1 g CMC to produce 70 mg globin). Tayot et al
(1985) absorbed heme using activated carbon in the presence of alcohol, at pH 3 and below 20
°C. Under these conditions activated carbon did not absorb globin and close to 100 % protein
was recovered. However, this method required a long residence time of up to 15 hours. Lee et al
(1990) developed an alternative to CMC adsorption using sodium alginate to bind heme under
James & Wells Ref: 134352NZ/47
various conditions. Optimized conditions (pH 2.25, 0.348% sodium chloride, and 0.107%
sodium alginate) gave 64.9% protein yield.
Proteolytic enzymes have been used to degrade hemoglobin and release the heme.
The released heme aggregates into micro droplets because of its hydrophobic nature. The amino
acids and peptides from the hydrolyzed protein can then be separated from the heme by
ultrafiltration or centrifugation. Pepsin, alcalase, and proteinase have been used to hydrolyze
hemoglobin. The degree of hydrolysis will affect yield and properties of the peptides. Peptide
yields reported in literature range from 65-85%. Strategies such as using exopeptidases for
controlling the extent of reaction have been included to increase yield and reduce bitterness that
can result from hydrolysis. The hydrolysates are not completely colorless and further treatment
to remove heme using activated carbon, ultrafiltration, and/or bentonite clay is often required.
Piot et al (1986) hydrolysed hemoglobin using pepsin at pH 2 for 3 hours. The peptides were
then passed through alumina columns which absorbed heme containing peptides. When
attempted on a large scale they had a protein yield of 25%. A white powder was obtained and
consisted of peptide chains ranging from 5-13 amino acids long. Gomez-Juarez et al (1999)
hydrolyzed hemoglobin using papain, a cysteine protease enzyme present in papaya, at pH 2.5
for 2 hours. The peptides were then ultrafiltered and decolorized using sodium hypochlorite at
room temperature.
Hydrogen peroxide has been used to destroy heme. De Buyser (1999) and Izumi et
al. (1991) suggest adding hydrogen peroxide to hemoglobin under alkaline conditions (pH 9-
12.5). Wismer-Pederson and Frohlich (1992) suggest treating the hemoglobin at pH 2-2.5. Red
blood cells are usually diluted to approximately 7% protein concentration. The amount of
hydrogen peroxide used ranges from 0.3-10 % (by protein solution weight). Residence times can
reach 25 hours and temperatures range from 20-90°C. Care must be taken when treating
hemoglobin with hydrogen peroxide because excessive hydrogen peroxide can result in the
oxidation of sulfur-containing amino acids in the protein and also cause a decrease in functional
properties. Other oxidizing agents that can be used include sodium peroxide, calcium peroxide,
potassium peroxide, and nitrates.
James & Wells Ref: 134352NZ/47
Metabolism results in the production of hydrogen peroxide in vivo. Catalase is a
natural defense mechanism against hydrogen peroxide. Catalase present in blood rapidly
decomposes hydrogen peroxide into water and oxygen causing large amounts of foam and poor
decolorization. Successful hydrogen peroxide treatment requires deactivation of catalase by
heating to 70°C or by mild acidic or alkaline treatment to denature the enzyme. When heat
treatment deactivates the catalase, the hemoglobin coagulates and loses its solubility in water.
All of the decolorization methods described above have been developed for using
decolorized red blood cells in human food. The methods would not be suitable for a bioplastics
application because they are expensive, take long periods of time, and can hydrolyze the protein.
All references, including any patents or patent applications cited in this specification
are hereby incorporated by reference. No admission is made that any reference constitutes prior
art. The discussion of the references states what their authors assert, and the applicants reserve
the right to challenge the accuracy and pertinence of the cited documents. It will be clearly
understood that, although a number of publications are referred to herein, this reference does not
constitute an admission that any of these documents form part of the common general knowledge
in the art, in New Zealand or in any other country.
It is an object of the present disclosure to address the foregoing problems or at least to
provide the public with a useful choice.
Further aspects and advantages of the present disclosure will become apparent from
the ensuing description which is given by way of example only.
BRIEF SUMMARY
The present disclosure provides methods for the manufacturing of plastic materials
from decolorized blood protein. In one embodiment, the method of decolorizing blood protein
and manufacturing the decolorized blood protein into a plastic material comprises:
- contacting the blood protein with an oxidizing agent to form a blood protein
composition that includes unreacted oxidizing agent;
James & Wells Ref: 134352NZ/47
- removing at least a portion of the oxidizing agent from the blood protein composition to
form a decolorized blood protein composition; and
- treating the decolorized blood protein composition in the presence of a plasticizer with
sufficient pressure and temperature to form the plastic material. In some embodiments, the
method further comprises contacting the decolorized blood protein composition with a
denaturing agent prior to the treating step. In some embodiments, the blood protein is selected
from the group consisting of whole blood, isolated red blood cells, serum, hemoglobin, blood
meal, spray dried hemoglobin, and mixtures thereof. In some embodiments, the blood protein is
blood meal or spray dried hemoglobin. In some embodiments, the blood protein is blood meal.
In some embodiments, the oxidizing agent is selected from the group consisting of peracetic
acid, hydrogen peroxide, sodium chlorite, and sodium hypochlorite. In some embodiments, the
oxidizing agent is peracetic acid. In some embodiments, the peracetic acid is provided as an
aqueous solution at a concentration of 1-5% peracetic acid by weight of the solution. In some
embodiments, the peracetic acid is provided as an aqueous solution at a concentration of 3-5%
peracetic acid by weight of the solution. In some embodiments, the denaturing agent is sodium
dodecyl sulfate (SDS). In some embodiments, the denaturing agent further comprises one or
more additives. In some embodiments, the one or more additives are selected from the group
consisting of borax, sodium silicate, sodium bentonite, amine modified clay, and mixtures
thereof. In some embodiments, the one or more additives are present at a concentration of 1-5
parts per hundred additive relative to the decolorized blood protein. In some embodiments, the
plasticizer is selected from the group consisting of ethylene glycol; diethylene glycol; triethylene
glycol (TEG); polyethylene glycol; glycerol; 1,2-propanediol; triacetin; triethyl citrate; tributyl
citrate; epoxidized soybean oil; and mixtures thereof. In some embodiments, the plasticizer is
selected from the group consisting of ethylene glycol; diethylene glycol; triethylene glycol;
polyethylene glycol; 1,2-propanediol; glycerol; and mixtures thereof. In some embodiments, the
plasticizer is triethylene glycol. In some embodiments, the plasticizer is present at a
concentration of about 10-30% plasticizer by weight of the decolorized blood protein. In some
embodiments, the plasticizer is present at a concentration of about 15-35% plasticizer by weight
of the decolorized blood protein. In some embodiments, the treating is conducted in the presence
of water at a concentration of 10-50% water by weight of the decolorized blood protein. In some
embodiments, the treating is conducted at a temperature of 80-130°C. In some embodiments, the
James & Wells Ref: 134352NZ/47
treatment is conducted at a pressure of1.5-2.9 MPa. In some embodiments, the blood protein is
blood meal, the denaturing agent is sodium dodecyl sulfate (SDS), and the plasticizer is
triethylene glycol. In some embodiments, the decolorized blood protein composition has a
percent whiteness of 35-100%. In some embodiments, the decolorized blood protein
composition has a percent whiteness of 50-100%. In some embodiments, the decolorized blood
protein composition has a percent whiteness of 60-100%. In some embodiments, the plastic
material has a tensile strength of 1.5-6 MPa. In some embodiments, the plastic material has a
stress at break of 0.25-1.5 mPa. In some embodiments, the plastic material has an elongation at
break of 15-40 mm. In some embodiments, the oxidizing agent is hydrogen peroxide. In some
embodiments, the hydrogen peroxide is provided as an aqueous solution at a concentration of 5-
40% hydrogen peroxide by weight of the solution. In some embodiments, the oxidizing agent is
sodium chlorite. In some embodiments, the sodium chlorite is provided as an aqueous solution
at a concentration of 1-10% sodium chlorite by weight of the solution. In some embodiments,
the oxidizing agent is sodium hypochlorite. In some embodiments, the sodium hypochlorite is
provided as an aqueous solution at a concentration of 5-15% sodium hypochlorite by weight of
the solution.
In further embodiments of the present disclosure, the blood protein is spray dried
hemoglobin. In some embodiments, the oxidizing agent is selected from the group consisting of
peracetic acid, hydrogen peroxide, sodium chlorite, and sodium hypochlorite. In some
embodiments, the oxidizing agent is peracetic acid. In some embodiments, the peracetic acid is
provided as an aqueous solution at a concentration of 2.5-3.5% peracetic acid by weight of the
solution. In some embodiments, the peracetic acid is provided as an aqueous solution at a
concentration of 2.5-3.5% peracetic acid by weight of the solution. In some embodiments, a
ratio of the aqueous solution of peracetic acid to spray dried hemoglobin is 2.5-3.5 : 1 by weight.
In some embodiments, a ratio of the aqueous solution of peracetic acid to spray dried
hemoglobin is 3 : 1 by weight. In some embodiments, the denaturing agent is sodium dodecyl
sulfate (SDS). In some embodiments, the denaturing agent is a mixture of sodium dodecyl
sulfate (SDS) and sodium sulfite (SS). In some embodiments, the plasticizer is selected from the
group consisting of diethylene glycol; triethylene glycol; polyethylene glycol; glycerol; 1,2-
propanediol; triacetin; triethyl citrate; tributyl citrate; epoxidized soybean oil; and mixtures
thereof. In some embodiments, the plasticizer is selected from the group consisting of ethylene
James & Wells Ref: 134352NZ/47
glycol; diethylene glycol; triethylene glycol; 1,2-propanediol; glycerol; and mixtures thereof. In
some embodiments, the plasticizer is ethylene glycol or glycerol. In some embodiments, the
plasticizer is 1,2-propanediol. In some embodiments, the plasticizer is triethylene glycol. In
some embodiments, the plasticizer is present at a concentration of about 15-35% plasticizer by
weight of the decolorized blood protein. In some embodiments, the treatment is conducted in the
presence of water at a concentration of 10-50% water by weight of the decolorized blood protein.
In some embodiments, the treatment is conducted at a temperature of 80-130°C. In some
embodiments, the treatment is conducted at a pressure of 1.5-2.9 MPa. In some embodiments,
the blood protein is spray dried hemoglobin, the denaturing agent is a mixture of sodium sulfite
and sodium dodecyl sulfate, and the plasticizer is ethylene glycol or glycerol. In some
embodiments, the blood protein is spray dried hemoglobin, the denaturing agent is sodium
dodecyl sulfate, and the plasticizer is ethylene glycol or glycerol. In some embodiments, the
decolorized blood protein composition has a percent whiteness of 35-100%. In some
embodiments, the decolorized blood protein composition has a percent whiteness of 50-100%.
In some embodiments, the decolorized blood protein composition has a percent whiteness of 60-
100%. In some embodiments, the plastic material has a tensile strength of 1.5-6 MPa. In some
embodiments, the plastic material has a stress at break of 0.25-1.5 mPa. In some embodiments,
the plastic material has an elongation at break of 15-40 mm. In some embodiments, the
oxidizing agent is hydrogen peroxide. In some embodiments, the hydrogen peroxide is provided
as an aqueous solution at a concentration of 5-40% hydrogen peroxide by weight of the solution.
In some embodiments, the oxidizing agent is sodium chlorite. In some embodiments, the sodium
chlorite is provided as an aqueous solution at a concentration of 1-10% sodium chlorite by
weight of the solution. In some embodiments, the oxidizing agent is sodium hypochlorite. In
some embodiments, the sodium hypochlorite is provided as an aqueous solution at a
concentration of 5-15% sodium hypochlorite by weight of the solution.
The present disclosure also provides a plastic material, comprising: (a) a blood
protein residue having a percent whiteness of 35%-100%; and (b) a plasticizer. In some
embodiments, the percent whiteness is 50%-100%. In some embodiments, the percent whiteness
is 60%-100%. In some embodiments, the plastic material further comprises a denaturing agent.
In some embodiments, the denaturing agent is sodium dodecyl sulfate (SDS), sodium sulfite
(SS), or a mixture thereof. In some embodiments, the denaturing agent is sodium dodecyl sulfate
James & Wells Ref: 134352NZ/47
(SDS). In some embodiments, the plasticizer is selected from the group consisting of diethylene
glycol; triethylene glycol; polyethylene glycol; glycerol; 1,2-propanediol; triacetin; triethyl
citrate; tributyl citrate; epoxidized soybean oil; and mixtures thereof. In some embodiments, the
plasticizer is selected from the group consisting of ethylene glycol; diethylene glycol; triethylene
glycol; 1,2-propanediol; glycerol; and mixtures thereof. In some embodiments, the plasticizer is
ethylene glycol or glycerol. In some embodiments, the plasticizer is 1,2-propanediol. In some
embodiments, the plasticizer is triethylene glycol. In some embodiments, the blood protein
residue comprises a blood protein and an oxidizing agent. In some embodiments, the oxidizing
agent is selected from the group consisting of peracetic acid, hydrogen peroxide, sodium chlorite,
sodium hypochlorite, and combinations thereof. In some embodiments, the oxidizing agent is
peracetic acid. In some embodiments, the oxidizing agent is hydrogen peroxide. In some
embodiments, the oxidizing agent is sodium chlorite. In some embodiments, the oxidizing agent
is sodium hypochlorite.
DESCRIPTION OF THE FIGURES
depicts the blood meal molecular weight after being treated with different
peracetic acid concentrations.
depicts the red blood cell molecular weight after being treated with peracetic
acid and other chemicals.
depicts the modified red blood cell molecular weight after being treated with
different chemicals.
depicts the x-ray diffraction (XRD) analysis of peracetic acid treated blood
meal.
depicts the Young’s modulus for 1-5% (w/w) peracetic acid treated blood
meal.
depicts the ultimate tensile strength for 1-5% (w/w) peracetic acid treated
blood meal.
depicts the stress at break for 1-5% (w/w) peracetic acid treated blood meal.
James & Wells Ref: 134352NZ/47
depicts the elongation at break for 1-5% (w/w) peracetic acid treated blood
meal.
depicts the percent whiteness for 1-5% peracetic acid treated blood meal
compression molded sheets.
depicts the ultimate tensile strength for 4% peracetic acid treated blood meal
with different additive concentrations.
depicts the Young’s modulus for 4% peracetic acid treated blood meal with
different additive concentrations.
depicts the stress at break for 4% peracetic acid treated blood meal with
different additive concentrations.
depicts the elongation at break for 4% peracetic acid treated blood meal with
different additive concentrations.
depicts the percent whiteness for 4% peracetic acid treated blood meal with
different additive concentrations.
depicts the x-ray diffraction pattern for 4% peracetic acid treated blood meal
with different concentrations of sodium bentonite.
depicts the x-ray diffraction pattern for 4% peracetic acid treated blood meal
with different concentrations of amine modified clay.
depicts the x-ray diffraction pattern for 4% peracetic acid treated blood meal
with different concentrations of borax.
depicts the x-ray diffraction pattern for 4% peracetic acid treated blood meal
with different concentrations of sodium silicate.
depicts extrusion and injection molding trials of decolorized blood meal.
James & Wells Ref: 134352NZ/47
depicts extrusion of decolored spray dried hemoglobin (SDH) with sodium
dodecyl sulfate (SDS) and sodium sulfite (SS) as denaturing agents.
(A) and 21(B) depict extrusion of decolored spray dried hemoglobin (SDH)
with sodium sulfite (SS) as the denaturing agent.
depicts compression molds of decolored spray dried hemoglobin. (A)
Formulation 11 with water (15 ppH), sodium dodecyl sulfate (3 ppH), and 1,2 propanediol (30
ppH). (B) Formulation 12 with water (25 ppH), sodium dodecyl sulfate (3 ppH), and 1,2
propanediol (30 ppH).
depicts injection molded samples of Formulation 12 (see, (B)) with
water (25 ppH), sodium dodecyl sulfate (3 ppH), and 1,2 propanediol (30 ppH).
depicts extrusion and injection molded samples of decolored blood meal
without use of a denaturing agent.
DETAILED DESCRIPTION
The following description sets forth exemplary methods, parameters and the like. It
should be recognized, however, that such description is not intended as a limitation on the scope
of the present disclosure but is instead provided as a description of exemplary embodiments.
1. Definitions
As used herein, the term “plastic material”, “plastic materials”, “plastics material”, or
“plastics materials” means any substance that is able to be molded or formed into a desired shape
or configuration. Preferably, the plastic material may have thermoplastic properties.
As used herein, the term “thermoplastic-like” or “thermoplastic” means that the
plastic material will soften and flow on the application of heat.
As used herein, the term “thermosetting-like” or “thermosetting” means that the
plastic material will not soften and flow on the application of heat. One skilled in the art would
realize the cross-links between adjacent proteins, or portions thereof, would need to be broken in
order for the plastic material to have thermoplastic properties.
James & Wells Ref: 134352NZ/47
As used herein, the term “blood meal,” means dried animal blood, usually bovine,
containing approximately 80% proteins, with hemoglobin accounting for 75% of the protein
content and plasma proteins the other 25%. The plasma proteins mainly consist of water soluble
albumin (60%), and salt soluble globulins (35%), and fibrinogen (4%). Blood meal has high
lysine content, and a high cysteine content of 1.4%.
As used herein, the term “blood protein residue,” means the residue that remains after
blood meal or any component of blood meal is treated with an oxidizing agent. The oxidizing
agents, may include, for example, peracetic acid, hydrogen peroxide, sodium chlorite, or sodium
hypochlorite. The blood protein residue may contain unreacted oxidizing agent.
As used herein, the term “high number of cross-links” means sufficient cross-links to
form at least a thermoplastic product, and if higher, a thermosetting product.
As used herein, the term “interactions between proteins” means any protein-protein
interaction which contributes to protein bonding or structure. Interactions may include, but are
not limited to disulphide bonds, hydrogen bonding, electrostatic interactions, Van der Waal
forces, ionic interactions and hydrophobic interactions.
As used herein, the term “denature” means that the protein has a loss of structural
order of at least some of the protein's secondary, tertiary or quaternary structure. This may
include the breaking of cross-linking or interactions, such as disulphide bonds, electrostatic
forces, hydrogen bonding and other protein interactions such as Van der Waal forces, or any
other protein-protein interactions between different portions of a protein structure or adjacent
proteins.
As used herein, the term “consolidate” means the decolorized protein solution
becoming solid or firm in the form of a plastics material.
As used herein, the term “comprise” shall have an inclusive meaning—i.e. that it will
be taken to mean an inclusion of not only the listed components it directly references, but also
other non-specified components or elements. This rationale will also be used when the term
“comprised” or “comprising” is used in relation to one or more steps in a method or process.
James & Wells Ref: 134352NZ/47
As used herein, the terms “decolorized” or “decolored” mean reduced in color
relative to the starting material prior to treatment with the decolorizing agent. The terms do not
mean 100% without any color.
2. Description
The present disclosure provides methods for the manufacturing of plastic materials
from a protein source, such as blood protein. The present disclosure also provides methods for
the manufacturing of plastic materials from decolorized blood protein. The present disclosure
also provides a plastic material including a blood protein residue having a percent whiteness of
%-100% and a plasticizer.
Plastic Materials Manufactured From A Protein Source Such as Blood Protein
According to one aspect of the present disclosure there is provided a method of
manufacturing a plastic material from a protein source, the method characterized by the
following steps;
i) treating the protein source with at least one denaturing agent to break interactions
between proteins or portions thereof, and
ii) treating the denatured protein source with sufficient pressure and temperature to
consolidate the denatured protein source into a plastic material.
In a preferred embodiment the method of manufacturing a plastic material from a
protein source, includes the additional step of:
iii) treating or adding to the denatured protein at least one additive or agent to control
or prevent further cross-links forming.
Preferably the plastics material may have thermoplastic properties. In a preferred
embodiment the plastics material may be stable under normal use, and malleable under the
correct temperature and/or pressure conditions. Alternatively the plastics material may have
thermosetting properties, and not be able to be re-plasticized once formed and cured into a shape.
James & Wells Ref: 134352NZ/47
In a preferred embodiment the protein source may be animal derived. For example,
waste protein from meat processing could be used as this is a plentiful and low cost source of
protein. However, this should not be seen as limiting, as in some cases plant based material may
be utilized with the present disclosure, such as soy.
In a preferred embodiment the protein source may be blood, and shall be referred to
as such herein. In a preferred embodiment the protein source may be whole blood. However,
this should not be seen as limiting as any protein containing fraction of blood may be utilized.
Protein containing fractions of blood may include isolated red blood cells, serum, or other
isolated fractions from whole blood.
However the use of blood as the protein source should not be seen as limiting. A
variety of other animal derived proteins may also be utilized with the present disclosure, for
example casein, or feather meal. Whole blood is a preferred raw protein source of the present
disclosure as it is a high volume waste product of abattoirs.
In New Zealand alone, 80000 tons of blood is collected annually as a by-product of
the meat industry. This is either disposed of or sold as low cost animal food or as fertilizer.
Proteins account for approximately 16-18% of raw blood, with 80% water content. In one
particularly preferred embodiment, the protein source utilized in the method of the present
disclosure is blood meal.
In most countries around the world blood from animal slaughter and meat processing
has to be collected and undergo suitable treatment prior to disposal. Given the high number of
animals being slaughtered daily to meet meat demands the volume of blood which has to be
disposed is considerable. Having to treat and dispose of blood as a waste product increases the
cost, labor, time and equipment required for animal and meat processing. The high volume of
blood which has to be disposed of provides a continuously available, high volume, low cost,
renewable and sustainable protein source.
In one preferred embodiment, the blood may be bovine blood, and shall be referred to
as such herein. Alternatively, the blood may be from other animal species such as pigs, sheep,
goats, horses or any other animal which has a high slaughter or meat processing rate. In a
James & Wells Ref: 134352NZ/47
preferred embodiment, the blood may be from an animal which leads to the highest volume of
blood for disposal in the geographical area of use.
The total volume of blood produced in an abattoir or meat processing plant is
calculated from the number of animals slaughtered multiplied by the volume of blood per
animal. For example, in New Zealand, and many other western countries, cattle are one of the
most common meat species. Cattle have a high volume of blood per animal, and a high number
of cattle being slaughtered and processed daily. Alternatively in countries such as New Zealand
which have a high sheep number and processing rates, blood from sheep may be utilized with the
present disclosure.
However, in other areas of the world, where cattle (or sheep) may not be the main
meat species, or result in the highest volume of waste blood, other animal blood may be
preferred for use with the present disclosure. Examples of other animal species which may be
utilized include pigs, chickens, camels, goats or horses.
In an alternative embodiment, the blood may be from a combination of two or more
animal species. For example, this may be the case when a combination of animal species is
being processed in a particular abattoir, or number of same.
According to another aspect of the present disclosure there is provided a
thermoplastic material, including:
a protein source, and
at least one denaturing agent,
characterized in that the protein source is blood, or a fraction thereof.
In a preferred embodiment, the thermoplastic material may also include at least one
additive or agent to control or prevent cross links forming. In a preferred embodiment, the raw
protein source may undergo at least one treatment step in order to form the protein source
utilized in the method of the present disclosure.
James & Wells Ref: 134352NZ/47
In one preferred embodiment, the raw protein source may be dried or concentrated to
form the protein source utilized in the present disclosure.
In a preferred embodiment, the protein source may have high protein content. In one
preferred embodiment, the protein source may have a protein content of at least 50%. In a
particularly preferred embodiment, the protein source may have a protein content of at least 70%,
and even more preferably a protein content of between 80 and 90%.
In an alternative embodiment, the protein source may have a protein source up to
approximately 90% protein. It should be noted that the protein content will depend on the
collection and processing of the protein source prior to use with the present disclosure.
It will be appreciated that the protein contents provided above relate to the protein
source as utilized in the method of the present disclosure. One skilled in the art would realize
that this could either be the raw protein source (if the protein content of this is sufficient), or
treated raw protein source, which has for example been dried or concentrated.
In the case where the protein source is blood, or a blood derived fraction then the
protein source will preferably be dried blood/blood fraction or blood/blood fraction meal. In a
preferred embodiment, the protein source may be dried whole blood; this consists of almost 90%
protein.
It will be appreciated by one skilled in the art that whole blood as collected from an
animal or abattoir has a protein content of approximately 16%. When this is dried the protein
content is increased to approximately 80 to 90%, by removal of water which makes up the
balance of the whole blood as collected.
As another example, corn gluten meal contains approximately 70% protein, again this
could be considered to be a high protein content.
In a preferred embodiment, the protein source may be predisposed to form a
sufficiently high number of cross-links or interactions to adjacent proteins, or other portions
within the same protein to form a strong, yet thermoplastic-like material.
James & Wells Ref: 134352NZ/47
Applicants have shown indirectly that by limiting or decreasing the number of cross-
links which form in the product the properties of the product can be controlled, resulting in a
product with either thermoplastic-like or thermosetting- like properties.
It will be appreciated by those skilled in the art that animal derived proteins,
especially those in blood have very high protein content, and are predisposed to forming a high
number of cross-links when heated. For this reason, animal derived proteins have previously
been very difficult to process.
It is well known to those skilled in the art, and in current literature that blood and
blood derived proteins are difficult to process. Previous work undertaken with blood proteins,
wherein experimentation looking at extrusion of blood proteins under high temperature
conditions of 180°C was undertaken, came to the conclusion that these proteins are not able to be
thermoplastically processed (Areas, 1992)
One significant advantage of the product and process of the present disclosure is that
it allows a thermoplastic-like product which will soften, flow and be re-moldable to be produced
from a protein source, such as blood proteins. The present disclosure allows a malleable and
extrudable material which is able to be reformed and therefore easily recycled to be produced
from a high volume, low cost protein source such as blood. This is something which has not
previously been achieved with blood proteins, and provides a significant advance in the field of
producing natural plastics materials.
The applicants anticipate that other animal derived proteins, such as casein could also
be used with the present disclosure. However, these are not the preferred protein source due to
their high price.
It is anticipated that the greater the proteins ability to reform cross-links during the
manufacturing process the more brittle the resulting plastics material will be, and the more
thermosetting-like properties the product will have.
Applicants have found that the use of particular denaturing agents and additives in the
processing of blood proteins allows a more ductile plastic material to be produced. This is due to
James & Wells Ref: 134352NZ/47
the potential use of appropriate additives to limit or prohibit the formation of cross-links during
the manufacturing process, and thus form a product with more thermoplastic-like properties.
In a preferred embodiment, the protein source may be in one of any number of
physical forms prior to processing. For example, the protein source may be in a liquid or
aqueous phase prior to and/or after the denaturing agent has been added. However, this should
not be seen as limiting as the protein source may also be in a dried, powdered, solid, slurry or
gel-like form prior to and/or after addition of the denaturing agent.
In a preferred embodiment, the denaturing agent may be any agent which results in
the denaturation of proteins into a lower structured or folded protein than the original protein.
In a preferred embodiment, the denaturing agent may act to disrupt or break protein-
protein interactions such that the protein is in a fully unfolded or secondary structure
configuration, and shall be referred to as such herein. However, this should not be seen as
limiting, as in some situations it may be desirable for the protein to retain some of its secondary,
tertiary, or quaternary structure.
In one preferred embodiment, the denaturing agent may be a combination of two or
more denaturing agents, and shall be referred to as such herein.
In a preferred embodiment one, of the denaturing agents may be sodium sulfite or a
functional equivalent thereof. Sodium sulfite is known to break disulphide bonds. Other
reducing agents can be used. However these are harmful and toxic, area not suitable for an
environmentally friendly material.
Sodium sulfite is added to proteins to cleave disulphide bonds that produce larger
aggregates insoluble even in urea (Areas, 1992).
The literature reveals that sodium sulfite solutions produced the best results in protein
extrusion, as measured by the decrease in viscosity of the extruded material, when used in 3-4
wt% of the protein concentration (Zhang et al 1998; Mizani et al, 2005; Orliac et al, 2003;
Barone and Schmidt et al, 2006).
James & Wells Ref: 134352NZ/47
Urea, sodium sulfite, metabisulfite, sulfuric acid, and ammonia can all be considered
as preservatives (hence anti-oxidant) for blood (Francis, 2000).
In a preferred embodiment, one of the denaturing agents may be urea or a functional
equivalent thereof. Urea is a denaturant, as well as a preservative in blood. Therefore, it may be
possible to substitute urea with any other compound having these functionalities. The addition
of urea to proteins is believed to break non-covalent interactions (hydrogen bonds, hydrophobic
and electrostatic interactions) (Areas, 1992). Usually it is effective only at high concentration (≥
8 M) (Lapanje, 1978).
It should be appreciated that one advantage of using a compound which is a
preservative is that it may also act as an anti-oxidant.
Urea, SDS and sulfuric acid are also denaturants.
In one preferred embodiment, the denaturing agent may be a combination of sodium
sulfite, or a functional equivalent thereof, and urea, or a functional equivalent thereof. In another
preferred embodiment, one of the denaturing agents may be SDS, or a functional equivalent
thereof.
Sodium dodecyl sulfate, also called sodium lauryl sulfate, has the structure of a long
acyl chain containing a charged sulfate group (Whitford, 2005). Sodium dodecyl sulfate (SDS)
is an ionic detergent. Detergents, by definition, unfold proteins and are effective protein
solubilizing agents. Detergents in general can asystematically bind to proteins, giving
uncertainties in comparisons of molecular weight. Any ionic detergent bound to the protein
would change the apparent charge and thus the isoelectric focusing mobility (Zewert et al, 1992).
SDS binds to almost all proteins destroying native conformation (Whitford, 2005). It
is known to disrupt hydrophobic interactions (Boye et al, 2004). SDS causes proteins to unfold,
become highly negatively charged and form rod-like protein micelles (Whitford, 2005).
In one preferred embodiment, the denaturing agent may be a combination of sodium
sulfite, or a functional equivalent thereof, and SDS, or a functional equivalent thereof.
James & Wells Ref: 134352NZ/47
In a particularly preferred embodiment, the denaturing agent may be a combination of
sodium sulfite, or a functional equivalent thereof, SDS, or a functional equivalent thereof, and
urea, or a functional equivalent thereof.
It is anticipated by the applicant's that while temperature and pressure can act as
denaturing agents, these, if used for this purpose would need to be combined with chemical
denaturation, using chemicals such as those described above.
In a preferred embodiment, sodium sulfite is used with SDS and/or urea.
In a preferred embodiment, the protein source, for example dried whole blood protein
may make up at least 20% (by weight) of the components in the mixture for processing.
In one preferred embodiment, the protein source may be present within a range of
substantially between 20 and 90 percent of the weight of the mixture for processing.
In one preferred embodiment, the protein source may be present within a range of
substantially between 45 and 55 percent of the weight of the mixture for processing.
Total Weight % range
Blood Meal Urea Water SS SDS
Min 46.73% Min 2.51% Min 12.99% Min 0.47% Min 1.45%
Max 77.52% Max 13.89% Max 42.33% Max 3.03% Max 7.35%
In a preferred embodiment, sodium sulfite may be present substantially between 1
and 10 percent of the weight of the mixture for processing. In a preferred embodiment sodium
sulfite may be present substantially between 1 and 4 percent of the weight of the mixture for
processing.
James & Wells Ref: 134352NZ/47
In a preferred embodiment, urea may be present substantially between 0 and 30
percent of the weight of the mixture for processing. In a preferred embodiment urea may be
present substantially between 15 and 25 percent of the weight of the mixture for processing.
In a preferred embodiment, sufficient denaturing agent may be provided to drive the
reaction to completion and in most embodiments all three denaturants are included.
In a preferred embodiment, SDS may be present substantially between 0 and 10
percent of the weight of the mixture for processing. In a preferred embodiment SDS may be
present substantially between 0.5 and 2.5 percent of the weight of the mixture for processing.
In a preferred embodiment, the remainder of the mixture for processing will be made
up of water. In a preferred embodiment water may be present at above substantially 20%
(weight/weight of blood meal), and preferably at approximately 60% (weight/weight of blood
meal) which is approximately 30% of total weight. In a preferred embodiment water may be
present at substantially between 5 and 50 percent of the weight of the mixture for processing.
It should be appreciated that the above concentrations are examples only, and may
differ depending on the combination of denaturing agents used in the preparation.
In a preferred embodiment, the denaturing agent may be in an aqueous solution.
Urea is believed to be interchangeable with SDS when used in combination with a
reducing agent. These may act by a similar mechanism; however, this has not been confirmed.
The applicants believe that the same product may be obtained when either of these additives is
used in the manufacture; however, this may have some differing properties such as strength,
brittleness, plasticity, or other physical or chemical properties.
The applicants anticipate that the combination of denaturing agents utilized in the
present disclosure results in the rearrangement of interactions between protein molecules which
leads to different structures which result in the blood proteins being more easily processed. In a
preferred embodiment, the denaturing agent may act to break the secondary and/or tertiary and/or
quaternary structure of, or between the proteins, however preferably they do not act to cleave the
primary protein amino acid (peptide) sequence. However, this should not be seen as limiting, as
James & Wells Ref: 134352NZ/47
in some embodiments, some cleaving of the protein source may be desirable. This may include
the breaking of disulphide bonds between adjacent proteins, or portions thereof. Cleaving of
disulfide or peptide bonds of at least a portion of the protein source may increase the strength or
desired properties of the plastics material, such as malleability and brittleness, or lack thereof.
This may result either directly from the cleaving action, or when additional additives, such as
plasticizers are included in the processing mixture.
In a preferred embodiment, at least one of the denaturing agents utilized may also act
to control or prevent cross links from forming during reconstitution of the protein source into a
plastics material, and shall be referred to as such herein. In an alternative embodiment,
additional additives may be utilized to control or prevent cross links from forming during
reconstitution of the protein source into a plastics material. In a preferred embodiment, sodium
sulfite may be the denaturing agent which acts to control or prevent cross links from forming.
Therefore, in preferred embodiments, the mixture to be processed may contain a sufficient
amount of sodium sulfite to prevent or control cross linking.
Sodium sulfite is known to act to break or cleave di-sulfide bonds between proteins or
portions thereof by the following reaction:
Sodium sulfite is bound up during this process. However, the use of excess sodium sulfite may
act to prevent (or break once formed) any new di-sulfide bonds from being formed. Sodium
James & Wells Ref: 134352NZ/47
sulfite is also believed to prevent the formation of cross-links between cysteine and/or serine
with lysine, which occur in alkaline conditions in the presence of heat.
Cysteine, a sulfur containing amino acid, is found to be involved in non-disulfide
irreversible covalent cross-linking (lysinoalanine and others) when proteins are placed under
high temperature. Lysinoalanine is an un-natural covalent crosslink that occurs through the
formation of dehydroalanine and reactive lysl residues occurs, in alkaline and heated systems.
Cystine disulfide bonds form dehydro-residues in alkaline conditions, which are the reactive
precursors for lysinoalanine. These non-disulfide covalent crosslinks once formed do not melt or
exchange at high temperatures (Mohammed et al, 2000). Their formation in a high protein
system can prevent a flowable melt material forming.
In a preferred embodiment, the formation of a plastics material may be due to the
formation of desirable secondary interactions between adjacent proteins, or portions thereof. For
example, the literature currently shows that reconfiguring a protein structure from an alpha-helix
structure to beta-sheet structure improves processing - i.e. interactions were broken and other
interactions were formed during processing.
The properties of the resulting plastics material is dependent upon the denaturing
agents utilized and the conditions under which consolidation occurs. These factors will influence
whether the plastics material is soft and pliable, i.e. thermoplastic-like, or hard and brittle, i.e.
thermosetting-like.
In a preferred embodiment, the denatured protein solution may be consolidated by the
treatment with a combination of high temperature and high pressure. It is anticipated that the
temperature and pressure provide a synergistic effect in addition to the denaturing agents
discussed above. This allows protein sources, which have previously not been processed into
plastics materials, to be utilized. It is anticipated that the pressure contributes to consolidation by
increasing the proximity between denatured proteins. This contributes and facilitates the
reformation of protein-protein interactions required to consolidate the denatured protein into the
final product - a plastics material. Another result of the high pressure may be that it contributes
to the denaturation of proteins, thereby exposing appropriate protein groups and side chains for
interaction with other adjacent proteins, or portions thereof.
James & Wells Ref: 134352NZ/47
It is anticipated that high temperature also facilitates the re-formation of protein-
protein cross-links and interactions. High temperature has previously been shown to cause or
increase the cross-linking or interaction between blood proteins. In a preferred embodiment, the
temperature required for the consolidation of the denatured protein source may be greater than
the activation temperature or energy required for the chemical reaction. It is also anticipated that
high temperature may decrease the viscosity of the system which in turn makes it easier for
components to react with one another. In a preferred embodiment, the temperature required for
the consolidation of the denatured protein source may be at least approximately 80°C. In a
preferred embodiment, the temperature utilized for the consolidation of the denatured protein
source using either extrusion or injection molding may be less than, or substantially 130°C. In
one preferred embodiment, the temperature may be 115°C. It should be appreciated that the
temperature used may depend on the method utilized to extrude or mold the plastic material. For
example lower temperatures would be likely to be utilized in an extruder than when injection
molding. This is due to water being able to exit the system as vapor, which is not possible
during injection molding.
Due to water being utilized as a plasticizer different properties of the plastics material
will also be obtained for different conditions in different methods. In a preferred embodiment,
the plastics material of the present disclosure may be molded using a closed system, such as
injection molding rather than an open system, such as an extruder. For example, using the same
components injection molding resulted in more desirable properties. This may be due to the
presence of “super-heated” water and higher pressure than what can be obtained in an extruder.
In an extruder, heated water can be lost as vapor and the majority of pressure is due to back
pressure. The injection mold cannot take powder material only granulated material. Therefore
injection molding occurs after extrusion.
In a preferred embodiment, the pressure required for the consolidation of the
denatured protein source may be at least approximately 5 MPa. In a preferred embodiment, the
pressure may be approximately 3 MPa. Pressure of this level is desired as it forces the
components into close proximity with one another, this is especially the case when the viscosity
of the processing mixture is high. The pressure utilized may also affect the reformation of di-
James & Wells Ref: 134352NZ/47
sulfide bonds. This may be due to the increased proximity of proteins or portions thereof, or the
presence of water at a high temperature and pressure.
It should be appreciated that in processes such as thermoforming (such as
compression molding) there is a relationship between the temperature and pressure required. For
example, as the temperature is lowered, higher pressure is required. This is due to the processing
mixture having a higher viscosity at lower temperatures, the mixture therefore requiring higher
pressure.
It should be appreciated that consolidation results from the formation of protein-
protein cross-links or interactions. These may be, or include any normal protein- protein
interaction between molecules. In a preferred embodiment, the processing mixture or slurry of
denatured protein may have increased temperature and pressure applied in a heated press, or
molding apparatus, such as those for extrusion or injection molding. However, this should not be
seen as limiting as any other suitable method known to one skilled in the art may be utilized in
the present disclosure. If cross-linking within the mixture can be controlled or prohibited during
consolidation it will also be possible to use other plastic molding methods, for example,
extrusion. At a sufficient temperature and pressure the denatured protein slurry solidifies into a
plastic material. So far the applicant's experimentation has shown that the resulting plastics
material may be either a thermoplastic-like plastic material product which can be remolded and
extruded, or a thermosetting-like plastic material product which does not soften when reheated.
The applicants believe that this may be controlled or altered by controlling the
number of cross-links which re-form during consolidation. For example, if less cross-links form
the product may have more thermoplastic properties. Alternatively, this property may be due to
a particular form of cross- linking or interaction being more prevalent. For example, a greater
number of disulphide bonds may provide more thermosetting properties than if a weaker
interaction were most prevalent, for example Van der Waal forces. This is due to the irreversible
nature of disulphide bonds, compared to other interactions which can be broken by increasing the
temperature, or alternatively the addition of plasticizers.
When controlling the reformation of cross-links it is anticipated that this may be
controlling of disulfide bridges between proteins or portions thereof. The strength of the final
James & Wells Ref: 134352NZ/47
product is, in part, provided by the reformation of cross- linking such as disulphide bonds and
secondary interactions.
In a preferred embodiment, the formation of cross-links and protein interactions
during consolidation may be controlled by the addition of chemicals which prevent these
interactions forming. The formation of cross-links is believed to be controlled and/or prevented
mainly by the action of the chemical denaturing agents, such as sodium sulfite. Di-sulfide bonds,
which are one of the main forms of cross-links controlled, can be broken by increased heat.
However, the heat required to break would also lead to the breaking of peptide bonds. This is
undesirable during the consolidation process. However, this should not be seen as limiting, as
the control and/or prevention of cross linking may be via physical means, or a combination of
physical and chemical means. It should be appreciated that the conditions need to be chosen
appropriately to minimize side reactions, such as cross-linking through cysteine and serine amino
acids.
In some embodiments, at least one further additive may be added to the protein slurry
to result in a thermoplastic-like product. Additional additives may include, but are not limited to
glycerol, PEG, oleic acid or other common plasticizers. The addition of plasticizers such as
these may also result in a lower amount of water being required. Water makes analyzing the
material difficult, and also water can evaporate changing the mechanical properties of the
material. Reducing the water content produces a stiffer the material. Applicants believe that the
denaturing agents utilized such as urea and SDS, which may be used as plasticizers in other
cases, do not act in this manner on their own. The present disclosure requires the use of
denaturing agents and water, which acts as a plasticizer.
In a preferred embodiment, the plastics material may be biodegradable. It should be
appreciated by one skilled in the art that if the product is not particularly biodegradable due to
high cross-linking or other reasons then biodegradability can be induced by adding at least one
chemical additive which can prevent the formation of disulphide bonds.
In some embodiments, the plastic material may be reinforced by the addition of fibers
to the protein slurry prior to treatment with temperature and pressure.
James & Wells Ref: 134352NZ/47
According to another aspect of the present disclosure, there is provided a plastics
material produced substantially by the method herein described. It is anticipated that the plastics
material may be used for a wide variety of purposes for example seeding planters, and as a
general material for building, pallets etc.
The protein based plastics material of the present disclosure have a number of
significant advantages over current plastics materials, including the following:
utilizes a high volume, low cost protein source,
allows production of a thermoplastic product which does not require the addition
of plasticizers,
environmentally friendly,
decreases the volume of petroleum based plastic material required, and
method of manufacture can be readily scaled up.
Plastic Materials Manufactured From Decolorized Blood Protein
The present disclosure also provides methods for the manufacturing of plastic
materials from decolorized blood protein. The methods are carried out by decolorizing the blood
protein and manufacturing the decolorized blood protein into a plastic material. The methods
comprise contacting the blood protein with an oxidizing agent to form a blood protein
composition that includes unreacted oxidizing agent; removing at least a portion of the unreacted
oxidizing agent from the blood protein composition to form a decolorized blood protein
composition; and treating the decolorized blood protein composition in the presence of a
plasticizer with sufficient pressure and temperature to form the plastic material. In some
embodiments, the method further comprises contacting the decolorized blood protein
composition with a denaturing agent prior to the treating step. In some embodiments, the
oxidizing agent is peracetic acid, hydrogen peroxide, sodium chlorite, sodium hypochlorite,
sodium chlorate, copper sulfate, sodium peroxide, calcium peroxide, potassium peroxide, or
nitrates. In some embodiments, the oxidizing agent is peracetic acid, hydrogen peroxide, sodium
James & Wells Ref: 134352NZ/47
chlorite, or sodium hypochlorite. In some embodiments, the oxidizing agent is peracetic acid. In
some embodiments, the oxidizing agent is hydrogen peroxide. In some embodiments, the
oxidizing agent is sodium chlorite. In some embodiments, the oxidizing agent is sodium
hypochlorite.
Peracetic acid (also known as peroxyacetic acid) is a clear liquid with a strong
vinegar smell and low pH. It is produced commercially by reacting acetic acid with hydrogen
peroxide in the presence of a catalyst and sold as an equilibrium mixture containing peracetic
acid, acetic acid, hydrogen peroxide and water. Non-equilibrium mixtures can be produced
using distillation to remove acetic acid, hydrogen peroxide, and water. The structure of peracetic
acid is as follows:
Due to growing concerns over the environmental impact of chlorine use, peracetic
acid has been suggested as an alternative for use in waste water treatment and pulp and textile
bleaching. Peracetic acid is also commonly used as a food and surface sanitizer. If discharged
into the environment, peracetic acid decomposes rapidly and bioaccumulation is unlikely to
occur.
In some embodiments, the blood protein source may be whole blood. However, this
should not be seen as limiting as any protein containing fraction of blood may be utilized.
Protein containing fractions of blood may include isolated red blood cells, serum, or other
isolated fractions from whole blood. As described above, the whole blood may be derived from
one or more animal species, such as, for example, bovines. In some embodiments, the blood
protein source may be blood meal or spray dried hemoglobin.
Blood Meal as Decolorized Blood Protein Source
In some embodiments, the blood protein source that is decolorized prior to
manufacturing into a plastic material is blood meal. In some embodiments where the blood
James & Wells Ref: 134352NZ/47
protein source is blood meal, 1-5% (weight/weight or “w/w”) peracetic acid solutions are used to
decolor the blood meal. In some embodiments, 3-5% (w/w) peracetic acid solutions are used to
decolor and deodor the blood meal. In some embodiments, 5-40% (w/w) hydrogen peroxide
solutions are used to decolor and deodor the blood meal. In some embodiments, 1-10% (w/w)
sodium chlorite solutions are used to decolor and deodor the blood meal. In some embodiments,
-15% (w/w) sodium hypochlorite solutions are used to decolor and deodor the blood meal.
Once the blood meal is decolorized and/or deodorized, a denaturing agent may or
may not be contacted with the decolorized blood composition prior to the treating step to form
the plastic material. Although a denaturing agent is not required to form a plastic material from
the decolorized blood composition, the denaturing agent may improve the quality of the plastic
material. In some embodiments, the denaturing agent is SDS. In some embodiments, one or
more additives may be combined with the denaturing agent before contacting with the
decolorized blood protein. In some embodiments, the additive is borax, sodium silicate, sodium
bentonite, amine modified clay (also referred to herein as “modified clay”), or mixtures thereof.
In some embodiments, the additives are added to the blood meal at a concentration of 1-5 parts
per hundred or “ppH” (e.g., 1-5 g per 100 g of blood meal). In some embodiments, the blood
meal is treated with a 4% peracetic acid solution prior to treatment with a denaturing agent in
combination with an additive.
In some embodiments, the plasticizer is ethylene glycol; diethylene glycol; triethylene
glycol (TEG); polyethylene glycol; glycerol; 1,2-propanediol; triacetin; triethyl citrate; tributyl
citrate; epoxidized soybean oil; or mixtures thereof. In some embodiments, the plasticizer is
ethylene glycol; diethylene glycol; triethylene glycol; polyethylene glycol; 1,2-propanediol;
glycerol; or mixtures thereof. In some preferred embodiments, the plasticizer is triethylene
glycol.
Spray Dried Hemoglobin as Decolorized Blood Protein Source
In some embodiments, the blood protein source that is decolorized prior to
manufacturing into a plastic material is spray dried hemoglobin. In some embodiments, the
spray dried hemoglobin is added to the oxidizing agent aqueous solution to decolor and/or
James & Wells Ref: 134352NZ/47
deodor the spray dried hemoglobin. In some preferred embodiments the spray dried hemoglobin
is added to the peracetic acid aqueous solution to decolor the spray dried hemoglobin.
In some embodiments where the blood protein source is spray dried hemoglobin, the
ratio of peracetic acid to spray dried hemoglobin (by weight) is 2.5-3.5 : 1. In some
embodiments, 2.5-3.5% (w/w) peracetic acid solutions are used to decolor the spray dried
hemoglobin. In some preferred embodiments, a ratio of about 3:1 peracetic acid to spray dried
hemoglobin with a 3% peracetic acid solution is used to decolor the spray dried hemoglobin.
Once the spray dried hemoglobin is decolorized, a denaturing agent may or may not
be contacted with the decolorized blood composition prior to the treating step to form the plastic
material. Although a denaturing agent is not required to form a plastic material from the
decolorized blood composition, the denaturing agent may improve the quality of the plastic
material. In some embodiments, the denaturing agent is SDS. In other embodiments, the
denaturing agent is a mixture of SDS and sodium sulfite (SS).
In some embodiments, the plasticizer is ethylene glycol; diethylene glycol; triethylene
glycol; polyethylene glycol; glycerol; 1,2-propanediol; triacetin; triethyl citrate; tributyl citrate;
epoxidized soybean oil; or mixtures thereof. In some embodiments, the plasticizer is ethylene
glycol; diethylene glycol; triethylene glycol; 1,2-propanediol; glycerol; or mixtures thereof. In
some preferred embodiments, the plasticizer is ethylene glycol or glycerol. In some preferred
embodiments, the plasticizer is 1,2-propanediol. In some preferred embodiments, the plasticizer
is triethylene glycol.
EXAMPLES
The following examples are offered to illustrate but not to limit the invention.
General Chemistry
Peracetic acid solutions (1-5% w/w) were prepared by diluting 5% peracetic acid with
the required amount of distilled water. A 15% peracetic acid sample was obtained from Degussa
New Zealand and used without modification. Freeze drying was accomplished with a Labconco
Freezone 2.5 Freeze Dryer, although samples may be alternatively dried in a normal oven. Color
James & Wells Ref: 134352NZ/47
analysis of dried powders was accomplished with a Minolta Chroma Meter CR-200b set in
L*a*b* (CIE 1976) mode using D (6504K) illuminant conditions. L*a*b* values were
converted to RGB and percent whiteness calculated using the equation: percent whiteness = (R +
G + B) / 765 x 100.
Peracetic acid treatment requires cooling the reaction vessel because heat is produced
during the decolorization treatment. The heat is caused by peracetic acid reacting with the iron
in blood meal as well as peracetic acid decomposition. The amount of heat generated increases
as the amount of blood meal being treated increases. Large batches will require sufficient
cooling and stirring to maintain the temperature at safe working limits and also to protect the
protein from thermal hydrolysis. Heat removed by cooling water can be cycled around the
processing plant for use in other areas.
The reaction vessel must also be vented to allow the release of gases given off during
the decolorization treatment. The main gases produced are oxygen and carbon dioxide. These
must be vented to prevent over pressurization of the reaction vessel.
Aqueous solutions of oxidizing agents were prepared by diluting commercially
available solutions or by dissolving the oxidizing agent in distilled water.
Example 1: Blood Meal Decolorization and Deodorization
5 g of blood meal (95% solids) were added to preweighed beakers. The blood meal
was treated with 20 mL of 1-5% (w/w) peracetic acid solutions or other oxidizing agents as
specified in Tables 1 and 2. The contents were stirred for 1 hour then filtered and washed with
distilled water using a Buchner funnel and Whatman grade 1 (11 µm cut off) filter paper. The
treated blood meal was freeze dried overnight. Dried samples were ground to a fine power using
a mortar and pestle and analyzed using the Chroma Meter. The color and odor analysis results
are reported in Tables 1 and 2.
Example 2: Red Blood Cell (RBC) Decolorization and Deodorization
5 g of red blood cells were added to preweighed beakers. The red blood cells were
treated with 20 mL of 1-5% (w/w) peracetic acid solutions or other oxidizing agents as specified
James & Wells Ref: 134352NZ/47
in Tables 1 and 3. The contents were stirred for 1 hour then freeze dried overnight. Dried
samples were ground to a fine power using a mortar and pestle and analyzed using the Chroma
Meter. The color and odor analysis results are reported in Tables 1 and 3.
Example 3: Modified Red Blood Cell (mRBC) Decolorization and Deodorization
5 g of red blood cells were added to preweighed beakers. The red blood cells were
diluted with 20 mL distilled water and lowered to pH 2 using 1 mol/L HCl. The solutions were
centrifuged at 4000 rpm for 5 minutes using a Sigma 6-15 centrifuge. The supernatant was
decanted and treated with 20 mL of oxidizing agents as specified in Tables 1 and 4. The
contents were stirred for 1 hour then freeze dried overnight. Dried samples were ground to a fine
power using a mortar and pestle and analyzed using the Chroma Meter. The color and odor
analysis results are reported in Tables 1 and 4.
Table 1. Blood meal (BM), red blood cell (RBC), and modified red blood cell (mRBC)
decolorization and deodorization methods with peracetic acid (PAA) ranked by percent
whiteness.
Rank Material Treatment L a* b* R G B Whiteness Smell
Treated Method (%) Modified?
1 RBC PAA (5%) 95 -4 17 243 242 208 91 Yes
2 mRBC PAA (5%) 91 0 17 239 229 199 87 Yes
3 BM PAA (15%) 84 0 35 227 208 144 76 Yes
4 BM PAA (5%) 77 3 43 215 187 111 67 Yes
BM PAA (4%) 74 4 43 208 178 104 64 Yes
6 BM PAA (3%) 72 6 41 206 172 103 63 Yes
7 BM PAA (2%) 64 7 36 182 149 91 55 No
8 BM PAA (1%) 54 8 30 155 124 79 47 No
9 RBC untreated 30 22 10 106 57 58 29 No
mRBC untreated 28 6 8 79 62 54 25 No
11 BM untreated 20 7 5 61 45 42 19 No
James & Wells Ref: 134352NZ/47
12 BM distilled 18 10 5 60 39 38 18 No
water
Table 2. Blood Meal (BM) decolorization and deodorization methods with oxidizing agents
ranked by percent whiteness.
Rank Material Treatment L R G B Whiteness Smell
Treated Method (%) Modified?
1 PAA 84 227 208 144 76 Yes
(15%)
2 PAA 77 215 187 111 67 Yes
(5%)
3 H O 67 187 154 109 59 Yes
(30%)
4 BM H O 66 183 153 102 57 No
(15%)
H O 52 149 119 79 45 No
(5%)
6 NaClO 35 103 77 56 31 Yes
(5%)
7 BM Untreated 20 61 45 42 19 No
8 BM NaClO 20 64 43 39 19 No
(5%)
9 BM NaClO 20 57 46 40 19 No
(10%)
BM NaClO 19 65 39 38 19 No
(5%)
11 BM NaClO 19 51 45 42 18 No
(15%)
12 BM Distilled 18 60 39 38 18 No
Water
13 BM ClO 18 60 39 38 18 No
(2%)
14 BM CuSO 19 51 45 40 18 No
(5%)
James & Wells Ref: 134352NZ/47
Table 3. Red blood cell (RBC) decolorization and deodorization methods with oxidizing agents
ranked by percent whiteness.
Rank Material Treatment L R G B Whiteness Smell
Treated Method (%) Modified?
1 RBC PAA 95 243 242 208 91 Yes
(5%)
2 RBC H O 77 218 184 139 71 Yes
(30%)
3 RBC NaClO 67 188 157 123 61 Yes
(5%)
4 RBC NaClO 65 165 157 144 61 No
(15%)
RBC NaClO 64 161 155 138 59 No
(10%)
6 RBC NaClO 58 148 138 132 55 No
(5%)
7 RBC ClO 35 126 63 62 33 No
(2%)
8 RBC CuSO 33 86 76 67 30 No
(5%)
9 RBC Untreated 28 106 57 58 29 No
NaClO 27 86 56 54 26 No
(5%)
James & Wells Ref: 134352NZ/47
Table 4. Modified red blood cell (mRBC) decolorization and deodorization methods with
oxidizing agents ranked by percent whiteness.
Rank Material Treatment L R G B Whiteness Smell
Treated Method (%) Modified?
1 mRBC NaClO 95 246 240 225 93 Yes
(5%)
2 mRBC PAA 91 239 229 199 87 Yes
(5%)
3 mRBC H O 64 180 147 92 55 Yes
(30%)
4 mRBC NaClO 49 125 115 100 44 No
(10%)
mRBC NaClO 47 121 110 102 44 No
(5%)
6 mRBC NaClO 47 129 107 94 43 No
(15%)
7 mRBC CuSO 29 82 65 52 26 No
(5%)
8 mRBC Untreated 28 79 62 54 25 No
9 mRBC ClO 27 79 60 51 25 No
(2%)
mRBC NaClO 23 69 51 46 22 No
(5%)
Example 4: Blood Meal and Red Blood Cell Molecular Mass Distribution
0.02 mol/L phosphate buffer containing 0.5% sodium sulfite, 0.1 M sodium chloride,
and 2 % sodium dodecyl sulfate at pH 7 was prepared by dissolving the required weights of
sodium dihydrogen phosphate, sodium dihydrogen orthophosphate, sodium sulfite, sodium
chloride, and sodium dodecyl sulfate in distilled water and adjusting to pH 7 using hydrochloric
acid or sodium hydroxide. 8-9 mg samples were dissolved in 2.5 ml 0.02 mol/L phosphate
buffer at pH 7 containing 0.5% SS, 0.1 M NaCl, and 2 % SDS and boiled for 5 minutes at 100°C.
Dissolved samples were run through a Superdex 200 10/300 gel filtration column attached to an
Akta Explorer 100 (GE Healthcare). The running buffer was 0.02 M phosphate buffer at pH 7
James & Wells Ref: 134352NZ/47
containing 0.1M NaCl and 0.1 % SDS at a flow rate of 0.5 ml/min. The protein concentration
measured at 215 nm using an inline detector. The molecular weight results of the blood meal,
red blood cell, and modified red blood cells after peracetic acid treatment are shown in 3.
Example 5: Ranking Methods Based on Combined Results for Peracetic Acid
The methods were ranked by combining the results for color removal, smell
modification, and protein molecular weight. Points were assigned to each component and the
methods ranked based on the highest total score. Ranking of the combined results are shown in
Table 5.
The points were assigned as follows:
Color: Max 100. Points assigned were equal to percentage whiteness. For example,
untreated BM is 19% white and is assigned 19 points.
Smell: Max 100. If the smell was improved – 100 points. If the smell was not
improved – 0 points.
Molecular weight: Max 100. If the main peak has not shifted from original column
volume position – 100 points. If the main peak has shifted to the right (increased column
volume) – 0 points.
James & Wells Ref: 134352NZ/47
Table 5. Blood meal (BM), red blood cell (RBC), and modified red blood cell (mRBC)
decolorization methods with peracetic acid (PAA) ranked based on combined results.
Rank Material Treatment Percent Smell Color Smell MW Total
Whiteness Modified (max 100) (max 100) (max 100) (max 300)
1 BM PAA 67 Yes 67 100 100 267
(5%)
2 BM PAA 64 Yes 64 100 100 264
(4%)
3 BM PAA 63 Yes 63 100 100 263
(3%)
12 RBC PAA 91 Yes 91 100 0 191
(5%)
14 mRBC PAA 87 Yes 87 100 0 187
(5%)
BM PAA 76 Yes 76 100 0 176
(15%)
19 BM PAA 55 No 55 0 100 155
(2%)
BM PAA 47 No 47 0 100 147
(1%)
RBC Untreated 29 No 29 0 100 129
28 mRBC Untreated 25 No 25 0 100 125
31 BM Untreated 19 No 19 0 100 119
36 BM Distilled 18 No 18 0 100 118
Water
Example 6: Ranking Methods Based on Combined Results for Oxidizing Agents
The methods were ranked by combining the results for color removal, smell
modification, simplicity of process, speed, environmental friendliness, and protein molecular
weight. Points were assigned to each component and the methods ranked based on the highest
total score. Ranking of the combined results are shown in Table 6.
James & Wells Ref: 134352NZ/47
The points were assigned as follows:
Color: Max 100. Points assigned were equal to percentage whiteness. For example,
untreated BM is 19% white and is assigned 19 points.
Smell: Max 100. If the smell was improved – 100 points. If the smell was not
improved – 0 points.
Simplicity of process: Max 100. If the process was simple, i.e. low volumes of
feedstocks being handled and few processing steps – 100 points. If the process required handling
high volumes of feedstocks and many processing steps (diluting, pH adjustment, centrifuging
etc.) – 0 points.
Speed: Max 100. If color and odor removal occurred within 5 minutes – 100 points.
If color and odor removal took longer than 5 minutes – 0 points.
Environmental Friendliness: Max 100. If there were no environmental concerns –
100 points. If there were environmental concerns – 0 points
Molecular Weight: Max 100. If the molecular mass was not significantly reduced
based on gel elution profiles and number average molecular weight – 100 points. If the
molecular mass was significantly reduced based on gel elution profiles and number average
molecular weight – 0 points.
Table 6. Blood meal (BM), red blood cell (RBC), and modified red blood cell (mRBC)
decolorization methods with oxidizing agents ranked based on combined results.
Ran Material Treatment Smell Color Smell Simplicity Speed Env. MW Total
k Modified Points Points Points Points Points Points Points
1 BM PAA Yes 76 100 100 100 100 100 576
(15%)
2 BM PAA Yes 67 100 100 100 100 100 567
(5%)
3 BM H O Yes 59 100 100 100 100 100 559
(30%)
4 BM H O No 57 0 100 100 100 100 457
(15%)
James & Wells Ref: 134352NZ/47
BM H O No 45 0 100 100 100 100 445
(5%)
6 RBC PAA Yes 91 100 0 100 100 0 391
(5%)
7 PAA Yes 87 100 0 100 100 0 387
mRBC
(5%)
8 RBC H O Yes 71 100 0 100 100 0 371
(30%)
9 H O Yes 55 100 0 0 100 100 355
mRBC
(30%)
BM Untreated No 19 0 100 0 100 100 319
11 BM Distilled No 18 0 100 0 100 100 318
Water
12 BM NaClO Yes 31 100 100 0 0 N/A 231
(5%)
13 RBCC Untreated No 29 0 0 0 100 100 229
14 Untreated No 25 0 0 0 100 100 225
mRBC
BM ClO No 18 0 100 0 0 100 218
(2%)
16 BM CuSO No 18 0 100 0 0 100 218
(5%)
17 mRBC NaClO Yes 93 100 0 0 0 0 193
(5%)
18 NaClO Yes 61 100 0 0 0 0 161
RBCC
(5%)
19 RBCC ClO No 33 0 0 0 0 100 133
(2%)
CuSO No 30 0 0 0 0 100 130
RBCC
(5%)
21 mRBC CuSO No 26 0 0 0 0 100 126
(5%)
22 RBCC NaClO No 26 0 0 0 0 100 126
(5%)
23 mRBC ClO No 25 0 0 0 0 100 125
(2%)
24 mRBC NaClO No 22 0 0 0 0 100 122
(5%)
BM NaClO No 19 0 100 0 0 N/A 119
(5%)
26 BM NaClO No 19 0 100 0 0 N/A 119
James & Wells Ref: 134352NZ/47
(10%)
27 NaClO No 19 0 100 0 0 N/A 119
(5%)
28 BM NaClO No 18 0 100 0 0 N/A 118
(15%)
29 RBC NaClO No 61 0 0 0 0 N/A 61
(15%)
RBC NaClO No 59 0 0 0 0 N/A 59
(10%)
31 RBC NaClO No 55 0 0 0 0 N/A 55
(5%)
32 mRBC NaClO No 44 0 0 0 0 N/A 44
(10%)
33 mRBC NaClO No 44 0 0 0 0 N/A 44
(5%)
34 mRBC NaClO No 43 0 0 0 0 N/A 43
(15%)
Example 7: X-ray Diffraction
The basal spacing and molecular patterning of polymers and nano-composites were
measured using a low angle powder X-ray diffraction. XRD was carried out using a Philips X-
ray diffractometer at a low angle configuration of 2θ = 2° to 12°, with a scanning rate of 2 θ = 2°
min , operating at a current of 40 mA and a voltage of 40 kV using CuKα radiation. The XRD
analysis of peracetic acid treated blood meal is shown in Increasing the peracetic acid
concentration causes a decrease in both inter-helix and intra-helix patterning (. This
shows that although chain length has not been severely reduced (, the amount of
interactions between proteins is reduced.
Example 8: Compression Molding of Decolored Blood Meal
3 ppH SDS was dissolved in 25 ppH distilled water (ppH relative to blood meal).
The solution was heated and stirred to 60°C. When producing composites or mixtures with
additives, the clay or additives were also added at this step. The hot solution was added to
decolored blood meal and mixed in a high speed mixer for 5 minutes. 20 ppH triethylene glycol
(TEG) was added and mixed for an additional 5 minutes (ppH relative to blood meal).
James & Wells Ref: 134352NZ/47
Four different additives were compared to each other: borax, sodium silicate, sodium
bentonite, and modified clay. Each of these was used with three different concentrations per 100
g of blood meal: 1 ppH, 3 ppH, and 5 ppH.
50 g of compression mixture was placed in the preheated mold and compression
molded at 110°C (top and bottom plate). 10 tons of pressure was applied for 5 minutes. Heating
was turned off after 5 minutes and the mold was left under 10 tons of pressure for a further 5
minutes. The pressure was released, the sheet removed and left to cool. The sheets were then
laser cut into Type 1 dog bone tensile test specimen.
Tensile specimens were conditioned for 7 days then mechanical properties were
examined using a Lloyd Tensile Tester LR 30K with a load cell of 500 N at a speed of 5
mm/min. All samples were assessed on their tensile strength, deflection at break, stress at break,
and Young’s modulus. The size of all tensile specimens was kept as constant as possible. Each
specimen was conditioned for 7 days prior to testing. Each sample was tested at a speed of 5
mm/min.
Sheet color was measured at three randomly selected locations using a Chroma Meter
set in L*a*b* (CIE 1976) mode using D (6504K) illuminant conditions. L*a*b* values were
converted to RGB and percent whiteness calculated and averages calculated as shown in Table 7.
As peracetic acid concentration increases percent whiteness of the compression molded sheet
increases. Higher concentrations of peracetic acid will have more active components causing
greater decoloring. Comparing Tables 1 and 7 shows that percent whiteness is slightly reduced
after compression molding into bioplastic sheets.
James & Wells Ref: 134352NZ/47
Table 7. Sheet color of 1-5% (w/w) peracetic acid.
L a* b* R G B Whiteness
Untreated BM 25 0 -1 59 60 61 24
26 0 0 62 62 62 24
1% PAA BM
2% PAA BM 28 12 6 86 59 58 27
3% PAA BM 57 18 52 182 123 43 45
4% PAA BM 71 2 54 199 171 72 58
% PAA BM 72 4 43 203 173 99 62
Increasing concentrations of peracetic acid caused Young’s modulus to decrease
significantly (. Standard BM has a modulus of 255.25 MPa, whereas 5% peracetic acid
has decreased to 38.44 MPa. The graph in also shows a slight increase in modulus of 4%
peracetic acid. As peracetic acid concentration increases the ultimate tensile strength lowers
(. Standard blood meal had an ultimate tensile strength of 10.40 MPa, whereas 5%
peracetic acid treated blood meal only gave 1.71 MPa. As shown in XRD analysis (
increasing peracetic acid treatment concentration causes a decrease in protein patterning which
could explain the decrease in strength.
Stress at break of samples has decreased as the concentrations of peracetic acid
increased (. Similar to previous figures, a significant change has occurred from the stress
required for standard BM of 2.08 MPa to stress required for 5% BM of 0.34 MPa. A similar
trend is seen in 8. The results obtained show a decrease in properties with increasing
concentration levels of peracetic acid. This could be due to the loss in cystein crosslinks caused
by peracetic acid treatment as described in literature. Peracetic acid treatment also causes a
decrease in its intermolecular and intramolecular interactions as shown by XRD analysis leading
to a more amorphous structure, which could also contribute to a decrease in strength.
James & Wells Ref: 134352NZ/47
Other factors that appeared to have an effect on mechanical properties were vapor
bubbles and specimen defects. These bubbles were noticed on the surface of 3-5% peracetic acid
specimens. Water vapor trapped in plastic sheets was observed to escape through the formation
of bubbles during the release of pressure while compression molding the sheets. While tensile
testing specimens, fractures were seen to be caused by bubbles as they showed tearing at the site
of bubbles. The 2% peracetic acid molded sheets which did not have many obvious bubbles,
showed a higher strength than 3% peracetic acid. However 1 and 2% peracetic acid compression
molded sheets were not as translucent, so bubbles could still be present but not as obvious due to
the lack of translucency.
Increasing the strength of peracetic acid treatment causes an increase in whiteness
(. Percent whiteness changes very little between 1 and 2% peracetic acid. However
between 2 and 3% peracetic acid concentration there is a large increase. At pH 2 the heme
porphyrin is released from the globin chain and makes it more susceptible to degradation. At 3%
peracetic acid concentration the pH could be sufficiently lowered to cause the release of heme
explaining the large increase in percent whiteness.
The 4% peracetic acid treatment was chosen as the best option to trial with clays and
additives. This was based on mechanical properties, smell, and color. Results are shown in
Table 8.
James & Wells Ref: 134352NZ/47
Table 8. Color change for different composite sheets (ppH relative to blood meal).
4% peracetic acid L a* b* R G B Whiteness
+ BM (%)
1 pph borax 64 8 48 187 149 68 53
59 15 51 183 131 50 48
3 pph borax
pph borax 48 24 38 162 97 51 41
1 pph sodium 54 18 41 172 117 59 45
silicate
3 pph sodium 53 18 35 168 114 68 46
silicate
pph sodium 56 16 43 176 123 60 47
silicate
1 pph bentonite 65 10 43 192 151 81 55
clay
3 pph bentonite 51 15 34 158 111 65 44
clay
pph bentonite 44 13 26 134 95 62 38
clay
1 pph modified clay 55 16 39 171 120 65 47
3 pph modified clay 57 16 42 179 124 64 48
pph modified clay 56 16 40 175 123 66 48
As the concentration of additives and clays increase, the whiteness levels decrease.
This can be the result of clays having a dark color. As the concentrations of clays increase,
plastic sheets incorporate more of their color giving less whiteness as well as transparency. As
James & Wells Ref: 134352NZ/47
shown in , a decrease in the ultimate tensile strength with the addition of additives was
observed apart from sodium bentonite at 3-5 pph (relative to blood meal). Modified clay, borax,
and sodium silicate decrease the strength of the bioplastic as their levels increase.
Young’s modulus increases as sodium bentonite and modified clay concentration
increases as shown in . Whereas sodium silicate and borax show addition causes a
decrease Young’s modulus as their concentrations increase. The largest increase in Young’s
modulus was exhibited by sodium bentonite, which could be a result of protein intercalation.
Sodium bentonite increases the stress at break. However modified clay, borax and
sodium silicate decrease the stress required at break as their concentration increases ().
The addition of borax increased the elongation required until fracture. However,
sodium silicate and both clays reduced the elongation (). This could be caused by the
increase in stiffness caused by these additives.
Whiteness levels decrease with the addition of clays and additives except sodium
silicate which gave a 2% increase in whiteness (). The decrease in whiteness is caused
by the incorporation of the clay or additives into the bioplastics matrix.
The graph shown in includes diffraction patterns for 4% peracetic acid
treated blood meal mixed with bentonite clay. In this graph, different concentrations of bentonite
clay are compared along with a standard blood meal mixture. A left shift in the pure bentonite
clay in the XRD spectra indicates an increase in basal spacing indicating intercalation of protein
between the clay layers (). Clay increases the interactions as it bonds to the protein. The
ordered structure provides the composite with a higher strength which is reflected in tensile
strength graphs in comparison to 4% peracetic acid. At low levels of clay, the level of
intercalation occurring is not enough to show up on the XRD graph. As the clay concentrations
increase, the peak starts to become more distinct (as seen in the peak of 5 pph bentonite) showing
an increase in basal spacing. Incorporation of bentonite also appears to affect the patterning
between helices. As the levels of clay increase the patterning between alpha helices also
increase. However, it did not seem to affect the patterning within the helical structure.
James & Wells Ref: 134352NZ/47
Amine modified clay is formed by inserting amine groups within bentonite clay
layers. Adding amine groups causes an increase in basal spacing compared with standard
bentonite clay, causing a XRD peak shift to left. Similarly to bentonite, intercalation occurs
between the clay layers with an increase in concentrations of clay. This is seen by 5 pph
modified amine clay having the highest peak. Unlike bentonite, the peak of 5 pph occurred to
the right instead of left side of the pure clay peak. This suggests that the basal spacing has
decreased. This indicates that the amine groups are getting replaced by the protein which is
confirmed by comparing and where the peaks have shifted to the same
location. Modified clay also shows an increase in inter helical patterning but does not affect the
intra helical patterning.
Borax causes a decrease in inter-helical patterning compared to other additives used
(). This could explain the decrease in mechanical properties when borax is added (-13).
Adding sodium silicate does not increase the inter-helical patterning. This is the
result of sodium silicate interacting with SDS. Both, sodium silicate and SDS repel each other as
they contain a negative charge, causing a decrease in bonds and interactions. This could explain
the decrease in mechanical properties when sodium silicate is added (-13 and ).
Additional data for extrusion and injection molding trials of decolorized blood meal
are summarized in .
Example 9: Decolorization of Spray Dried Hemoglobin (SDH)
Peracetic solutions were prepared using a 5% stock solution. SDH (50 g) was
combined with the appropriate amount of peracetic acid gradually and mixed in a blender at high
speed for 10 to 12 minutes. The blended mixture was washed with 200 g distilled water by
manually stirring the mixture for 5 minutes. The solids were separated from the liquid solution
using a cheese cloth. The mixture was neutralized by adjusting the pH to 7 using 1 M NaOH
after adding 150 g distilled water. The solids were separated from the solution using a cheese
cloth. The solids were dried in a fan forced oven at 60°C for 35 hours. The dried and decolored
SDH was powdered using a micro grinder. At the initial mixing stage the SDH with peracetic
James & Wells Ref: 134352NZ/47
acid becomes mushy and increases in volume. As mixing proceeds the volume shrinks and the
speed of the mixer must be reduced. Addition of SDH into the peracetic acid solution resulted in
complete mixing with a shorter mixing time (less than 15 min) compared to adding peracetic
acid to SDH. The standard mixing time was 15 minutes. Processing of SDH and peracetic acid
with different ratios of peracetic acid to SDH (1.5:1, 2.5:1, 3:1, and 4:1) and different peracetic
acid concentrations (1-5% w/w) were performed.
At 3:1 peracetic acid to SDH ratio the following results were obtained:
PAA Concentration 0.5%. SDH and PAA did not mix well, remained a slurry and
large amounts of foam was produced. Decolorization was not achieved, filtration was difficult,
and the mixture could not be processed.
Concentration 1%. Hardly removed color from SDH and bit thicker than 0.5%.
Washing caused some dissolution, so no further steps could be taken. The filtration was
difficult, and the mixture could not be processed.
Concentration 2%. Effective mixing was achieved, decolored well, and a large
amount of foam was produced during neutralizing that can only be removed with cheese cloth.
The end product could be processed.
Concentration 3%. Effective mixing was achieved and decolored better than 2%, and
did not produce significant amounts of foam during neutralizing and had minimal waste
compared to 1 and 2% PAA. The end product was easy to filter and could be processed.
Concentration 4%. Became viscous and formed clumps resulting in ineffective
mixing, but decolored well. Final product still had a strong acetic acid smell.
Concentration 5%. Highly decolored, but the end product was extremely sticky and
became very rubbery making washing and filtration difficult. A very strong acetic acid odor
remained in final product.
At 1.5:1 peracetic acid to SDH ratio the following results were obtained:
James & Wells Ref: 134352NZ/47
Concentration 1%. Mixed well and gave granular particles, but did not decolor at all.
The end product was easy to filter.
Concentration 2%. Mixed well, but minimal decolorization took place. The end
product was easy to filter.
Concentration 3%. Mixed well and decolored well. The end product was easy to
filter.
Concentration 4%. Mixed well and decolored well, but the end product became
sticky during mixing. The end product could not be processed.
Concentration 5%. The end product became very sticky after mixing. Decolorization
optimal. The end product was difficult to wash and filter and could not be processed.
For all peracetic acid concentrations using a 1.5:1 peracetic acid to SDH ratio, blends
became very hard and dry after mixing. It would be appear that SDH is able to absorb all the
peracetic acid solution at this ratio making further processing very difficult.
At 4:1 and 5:1 peracetic acid to SDH ratio the following results were obtained:
Concentration 1%. Mixed well and gave granular particles, but did not decolor at all.
Concentration 2%. The consistency was a bit thicker compared to using 1% peracetic acid, but
the mixture was still frothy and dispersed in water. The end product could not be processed.
Concentration 3%. The consistency was even thicker, it could still be washed, but
neutralizing resulted in the formation of thick slurry, and the end product could not be filtered.
Concentration 4% and 5%. Mixed well and decolored well, but the end product
became sticky. At 5% PAA it became very hard and couldn’t be filtered.
It was found that a ratio of 3:1 (peracetic acid:SDH), using a peracetic acid
concentration of 3% was optimal in terms of ability of the end product to be processed, degree of
decoloring, and that the parameters should be used in further processing and testing. With a ratio
2.5:1, SDH mixed, decolored well, and the end product can be processed. Ratio 3:1 worked well
James & Wells Ref: 134352NZ/47
with peracetic acid concentrations of 2.5% and 3.5% and the difference in degree of
decolorization can be visualized with the naked eye. It is also clear that decolored SDH becomes
sticky with ratios exceeding 3:1, since 3.5:1 gave a sticky final product with a strong acidic odor.
Samples were color analyzed and the results are summarized in Table 9.
In conclusion, the degree of decoloring increased with an increase in concentration
and ratio of PAA:SDH. The consistency of the PAA/SDH mixture became thicker with an
increase in PAA concentration and ratio of PAA:SDH. Using a PAA concentration of more than
3% made the SDH/PAA mixture sticky and mixing difficult. Ratios of 2.5:1 and 3:1 PAA:SDH
are reliable methods at PAA concentration of 2.5% and 3% to effectively decolor and process
SDH.
James & Wells Ref: 134352NZ/47
Table 9. Chromameter analysis of spray dried hemoglobin (SDH) decolored with peracetic acid
(PAA).
Ratio Conc. Amount Cost of L A B R G B % Whiteness
PAA (Kg) of PAA ($4
% PAA per Kg)
required
for 1Kg
of SDH
1.5:1 1% 0.3 1.2 18 7 10 58 40 31 17%
0.6 2.4 62 11 40 184 142 79 53%
1.5:1 2%
1.5:1 3% 0.9 3.6 81 15 62 251 190 83 68%
1.5:1 4% 1.2 4.8 86 11 57 252 207 129 77%
2.5:1 2.5% 1.25 5 94 11 59 255 232 126 80%
2.5:1 3% 1.5 6 95 11 69 255 241 112 79%
2 8 102 7 51 255 249 156 86%
2.5:1 4%
3.0:1 2% 1.2 4.8 105 7 58 255 248 148 85%
3.0:1 2.5% 1.5 6 113 2 52 255 252 154 86%
1.8 7.2 115 -10 50 255 255 157 87%
3.0:1 3%
3.0:1 3.5% 2.1 8.4 115 -20 49 250 255 141 84%
3.0:1 4% 2.4 9.6 116 -18 54 247 255 148 85%
3.0:1 5% 3 12 117 -18 54 239 255 147 84%
3.5:1 2.5% 1.75 7 116 -17 49 243 255 158 86%
2.1 8.4 117 -21 49 239 255 158 85%
3.5:1 3%
3.5:1 3.5% 2.45 9.8 118 -30 52 239 255 152 84%
James & Wells Ref: 134352NZ/47
Example 10: Compression Molding of Decolored Spray Dried Hemoglobin (SDH)
Sodium dodecyl sulfate (SDS) and plasticizer were dissolved in distilled water and
the solution was stirred at 60°C for 5 minutes. SDH decolored with a PAA concentration of 5%
was stirred into the SDS solution with a mixer for 5 to 6 minutes. The mixture was washed and
filtered as in Example 9, and equilibrated for 10 to 12 hours before processing. The washed and
filtered SDH sample (55 g) was placed between the upper and lower plates of the compression
mold. The compression mold upper plate temperature was 165°C, and the upper mold reached
110°C. The lower plate temperature was 160°C, and the lower mold reached 110°C. A pressure
of 10 tons compressed the decolored SDH. Higher pressures led to squeezing of the material out
of the mold. Formulations with 20 ppH water, 3 or 6 ppH SDS, and 20 ppH triethylene glycol
showed good consolidation and flowability.
SDH decolored with 2% PAA used for compression molding trials resulted in sheets
that darkened during processing. SDH decolored with 4% PAA resulted in sheets that remained
yellow and were more transparent compared to those made with 2% PAA SDH. When the
amount of SDS and TEG were increased, the flowability increased significantly; however,
optimal quality sheets could not be achieved as material is pressed out of the mold. Different
types of plasticizers (other than TEG), such as triacetin, DEG, and ethylene glycol may help
improve processing.
Example 11: Extrusion of Decolored Spray Dried Hemoglobin (SDH) With SDS and SS as
Denaturing Agents
Water (20 ppH), SDS (6 ppH), SS (3 ppH), and plasticizer (30 ppH) were combined
with 100 parts of SDH decolored with 3% peracetic acid to achieve reasonable extrusion.
Ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, glycerol, triacetin,
triethyl citrate, tributyl citrate, 1,2-propanediol, and epoxidized soy bean oil were used as
plasticizers. SS does not improve consolidation. Ethylene glycol and glycerol consolidated the
decolored spray dried hemoglobin with a smooth and continuous extrudate. The torque was kept
between 8.4 and 9 Newton-meters, pressure ranged from 15-22 bar, the rpm was 150, the auger
speed (screw feeder) was 8-9 Hz, and a pH of 7 was used for all formulations except indicated.
A temperature of more than 125°C darkens the material. No difference was observed when the
James & Wells Ref: 134352NZ/47
pH was varied from 4, 7, and 10. 1,2-propanediol gave effective flowability during processing.
The results are summarized in .
Example 12: Extrusion of Decolored Spray Dried Hemoglobin with SDS as a Denaturing Agent
Water (15-40 ppH), SDS (3-6 ppH), and plasticizer (30 ppH) were combined with
100 parts of SDH decolored with 3% peracetic acid to achieve reasonable extrusion. Ethylene
glycol, diethylene glycol, triethylene glycol, polyethylene glycol, glycerol, triacetin, triethyl
citrate, tributyl citrate, 1,2-propanediol, and epoxidized soy bean oil were used as plasticizers.
Ethylene glycol and glycerol consolidated the decolored spray dried hemoglobin with a smooth
and continuous extrudate. The torque was kept between 8.4 and 9 Newton-meters, pressure
ranged from 15-22 bar, the rpm was 250, the auger speed (screw feeder) was 8-9 Hz, and a pH of
7 was used for all formulations except indicated. A temperature of more than 125°C darkens the
material. No difference was observed when the pH was varied from 4, 7, and 10. 1,2-
propanediol gave effective flowability during processing. The addition of SS did not make any
improvement in consolidation. A high amount of water content (40 ppH) helped to avoid grainy
surfaces on the extrudate. The lowest amount of water content tested (15 parts) made the
extrudate very brittle. The results are summarized in .
Example 13. Compression Molding of Spray Dried Hemoglobin Extrudate Formulations
Compression molds with the most promising extrudate formulations 11 and 12 from
Example 12 were performed. The compression mold upper plate temperature was 175°C, and
the upper mold reached 120°C. The lower plate temperature was 170°C, and the lower mold
reached 120°C. Formulation 11 with water (15 ppH), SDS (3 ppH), and 1,2 propanediol (30
ppH) and formulation 12 with water (25 ppH), SDS (3 ppH), and 1,2 propanediol (30 ppH) gave
promising results as shown in .
Example 14: Injection Molding of Decolored Spray Dried Hemoglobin
Formulation 12 with water (25 ppH), SDS (3 ppH), and 1,2 propanediol (30 ppH) was
extruded and the extrudates were granulated and fed into the barrel of the injection molding
machine. The material turned darker than its original color when fed into the injection barrel.
When the material stayed more than five minutes in the barrel, the material turned darker. The
James & Wells Ref: 134352NZ/47
material should not be in the barrel for more than 3 minutes. Colorant may be added before
extrusion to get colored injection molded samples. Injection molded samples are shown in FIG.
Example 15: Extrusion and Injection Molding of Decolored Blood Meal in the Absence of a
Denaturing Agent
Water (30-50 ppH) and plasticizer (20-30 ppH) were combined with 100 parts
decolored blood meal and extruded. The torque was kept between 8.4 and 9 Newton-meters,
pressure ranged from 15-22 bar, the rpm was 150, the auger speed (screw feeder) was 8-9 Hz,
and a pH of 7 was used for all formulations. The extrudates were granulated and fed into the
barrel of the injection molding machine. The results are summarized in . This example
demonstrates that decolored blood meal may be treated with a plasticizer to form a plastic
material in the absence of added denaturing agent.
Example 16: Odor Results for Extrusions with Bloodmeal Treated with Oxidizing Agents
Extrusions with 3% peracetic acid treated bloodmeal resulted in the extrudate exiting
the extruder as either a powder or small sections of compressed powder. When pre-extrusion
mixtures where being produced a strong acetic acid smell was observed but the characteristic
bloodmeal smell did not return.
Extrusions with peracetic acid treated bloodmeal where the acetic acid was not
neutralized resulted in compressed powders and no melt formation (type one). A strong acetic acid
smell was also observed during mixing and extrusion.
Initial extrusion trials using PAA, hydrogen peroxide and sodium chlorite treated
bloodmeal were carried out using the standard formula (10 pph urea, 3 pph sodium sulphite,
BM BM
3 pph SDS, 60 pph water, 10 pph TEG) for processing untreated bloodmeal into
BM BM BM
Novatein Thermoplastic Protein (NTP). Hydrogen peroxide and sodium chlorite treated
bloodmeal extrusions were unsuccessful and resulted in the extruder blocking, as well as the
return of the bloodmeal smell.
James & Wells Ref: 134352NZ/47
Claims (65)
1. A method of decolorizing blood protein and manufacturing the decolorized blood protein into a plastic material, the method comprising: - contacting the blood protein with an oxidizing agent to form a blood protein composition that includes unreacted oxidizing agent; - removing at least a portion of the unreacted oxidizing agent from the blood protein composition to form a decolorized blood protein composition; and - treating the decolorized blood protein composition in the presence of a plasticizer with sufficient pressure and temperature to form the plastic material.
2. The method of claim 1, further comprising contacting the decolorized blood protein composition with a denaturing agent prior to the treating step.
3. The method of claim 1 or claim 2, wherein the blood protein is selected from the group consisting of whole blood, isolated red blood cells, serum, hemoglobin, blood meal, spray dried hemoglobin, and mixtures thereof.
4. The method of any of claims 1-3, wherein the blood protein is blood meal or spray dried hemoglobin.
5. The method of any of claims 1-4, wherein the blood protein is blood meal.
6. The method of any of claims 1-5, wherein the oxidizing agent is selected from the group consisting of peracetic acid, hydrogen peroxide, sodium chlorite, sodium hypochlorite, and combinations thereof.
7. The method of claims 1-6, wherein the oxidizing agent is peracetic acid.
8. The method of claim 7, wherein the peracetic acid is provided as an aqueous solution at a concentration of 1-5% peracetic acid by weight of the solution. James & Wells Ref: 134352NZ/47
9. The method of claim 8, wherein the peracetic acid is provided as an aqueous solution at a concentration of 3-5% peracetic acid by weight of the solution.
10. The method of claim 2, wherein the denaturing agent is sodium dodecyl sulfate (SDS).
11. The method of claim 2, wherein the denaturing agent further comprises one or more additives.
12. The method of claim 11, wherein the one or more additives are selected from the group consisting of borax, sodium silicate, sodium bentonite, amine modified clay, and mixtures thereof.
13. The method of claim 12, wherein the one or more additives are present at a concentration of 1-5 parts per hundred additive relative to the decolorized blood protein.
14. The method of any of claims 1-13, wherein the plasticizer is selected from the group consisting of ethylene glycol; diethylene glycol; triethylene glycol (TEG); polyethylene glycol; glycerol; 1,2-propanediol; triacetin; triethyl citrate; tributyl citrate; epoxidized soybean oil; and mixtures thereof.
15. The method of any of claims 1-14, wherein the plasticizer is selected from the group consisting of ethylene glycol; diethylene glycol; triethylene glycol; polyethylene glycol; 1,2- propanediol; glycerol; and mixtures thereof.
16. The method of any of claims 1-15, wherein the plasticizer is triethylene glycol.
17. The method of any of claims 14-16, wherein the plasticizer is present at a concentration of about 10-30% plasticizer by weight of the decolorized blood protein.
18. The method of any of claims 1-17, wherein the blood protein is blood meal, the denaturing agent is sodium dodecyl sulfate (SDS), and the plasticizer is triethylene glycol.
19. The method of claim 2, wherein the blood protein is spray dried hemoglobin.
20. The method of claim 19, wherein the oxidizing agent is peracetic acid. James & Wells Ref: 134352NZ/47
21. The method of claim 20, wherein the peracetic acid is provided as an aqueous solution at a concentration of 2.5-3.5% peracetic acid by weight of the solution.
22. The method of any of claims 19-21, wherein a ratio of the aqueous solution of peracetic acid to spray dried hemoglobin is 2.5-3.5 : 1 by weight.
23. The method of any of claims 19-22, wherein a ratio of the aqueous solution of peracetic acid to spray dried hemoglobin is 3 : 1 by weight.
24. The method of any of claims 19-23, wherein the denaturing agent is sodium dodecyl sulfate (SDS).
25. The method of any of claims 19-24, wherein the denaturing agent is a mixture of sodium dodecyl sulfate (SDS) and sodium sulfite (SS).
26. The method of any of claims 19-25, wherein the plasticizer is selected from the group consisting of diethylene glycol; triethylene glycol; polyethylene glycol; glycerol; 1,2- propanediol; triacetin; triethyl citrate; tributyl citrate; epoxidized soybean oil; and mixtures thereof.
27. The method of any of claims 19-26, wherein the plasticizer is selected from the group consisting of ethylene glycol; diethylene glycol; triethylene glycol; 1,2-propanediol; glycerol; and mixtures thereof.
28. The method of any of claims 19-27, wherein the plasticizer is ethylene glycol or glycerol.
29. The method of any of claims 19-28, wherein the plasticizer is 1,2-propanediol.
30. The method of any of claims 19-29, wherein the plasticizer is triethylene glycol.
31. The method of any of claims 1-30, wherein the plasticizer is present at a concentration of about 15-35% plasticizer by weight of the decolorized blood protein.
32. The method of any of claims 1-31, wherein the treating is conducted in the presence of water at a concentration of 10-50% water by weight of the decolorized blood protein. James & Wells Ref: 134352NZ/47
33. The method of any of claims 1-32, wherein the treating is conducted at a temperature of 80-130°C.
34. The method of any of claims 1-33, wherein the treating is conducted at a pressure of 1.5- 2.9 MPa.
35. The method of claim 2, wherein the blood protein is spray dried hemoglobin, the denaturing agent is a mixture of sodium sulfite and sodium dodecyl sulfate, and the plasticizer is ethylene glycol or glycerol.
36. The method of claim 2, wherein the blood protein is spray dried hemoglobin, the denaturing agent is sodium dodecyl sulfate, and the plasticizer is ethylene glycol or glycerol.
37. The method of any of claims 1-36, wherein the decolorized blood protein composition has a percent whiteness of 35-100%.
38. The method of any of claims 1-37, wherein the decolorized blood protein composition has a percent whiteness of 50-100%.
39. The method of any of claims 1-38, wherein the decolorized blood protein composition has a percent whiteness of 60-100%.
40. The method of any of claims 1-39, wherein the plastic material has a tensile strength of 1.5-6 MPa.
41. The method of any of claims 1-40, wherein the plastic material has a stress at break of 0.25-1.5 mPa.
42. The method of any of claims 1-41, wherein the plastic material has an elongation at break of 15-40 mm.
43. The method of any of claims 1-6, wherein the oxidizing agent is hydrogen peroxide.
44. The method of claim 43, wherein the hydrogen peroxide is provided as an aqueous solution at a concentration of 5-40% hydrogen peroxide by weight of the solution. James & Wells Ref: 134352NZ/47
45. The method of any of claims 1-6, wherein the oxidizing agent is sodium chlorite.
46. The method of claim 45, wherein the sodium chlorite is provided as an aqueous solution at a concentration of 1-10% sodium chlorite by weight of the solution.
47. The method of any of claims 1-6, wherein the oxidizing agent is sodium hypochlorite.
48. The method of claim 47, wherein the sodium hypochlorite is provided as an aqueous solution at a concentration of 5-15% sodium hypochlorite by weight of the solution.
49. A plastic material, comprising: (a) a blood protein residue having a percent whiteness of 35%-100%; and (b) a plasticizer.
50. The plastic material of claim 49, wherein the percent whiteness is 50%-100%.
51. The plastic material of claim 49, wherein the percent whiteness is 60%-100%.
52. The plastic material of any one of claims 49-51, further comprising a denaturing agent.
53. The plastic material of claim 52, wherein the denaturing agent is sodium dodecyl sulfate (SDS), sodium sulfite (SS), or a mixture thereof.
54. The plastic material of claim 53, wherein the denaturing agent is sodium dodecyl sulfate (SDS).
55. The plastic material of any one of claims 49-54, wherein the plasticizer is selected from the group consisting of diethylene glycol; triethylene glycol; polyethylene glycol; glycerol; 1,2- propanediol; triacetin; triethyl citrate; tributyl citrate; epoxidized soybean oil; and mixtures thereof.
56. The plastic material of any one of claims 49-55, wherein the plasticizer is selected from the group consisting of ethylene glycol; diethylene glycol; triethylene glycol; 1,2-propanediol; glycerol; and mixtures thereof. James & Wells Ref: 134352NZ/47
57. The plastic material of any one of claims 49-56, wherein the plasticizer is ethylene glycol or glycerol.
58. The plastic material of any one of claims 49-57, wherein the plasticizer is 1,2- propanediol.
59. The plastic material of any one of claims 49-58, wherein the plasticizer is triethylene glycol.
60. The plastic material of any one of claims 49-59, wherein the blood protein residue comprises a blood protein and an oxidizing agent.
61. The plastic material of claim 60, wherein the oxidizing agent is selected from the group consisting of peracetic acid, hydrogen peroxide, sodium chlorite, sodium hypochlorite, and combinations thereof.
62. The plastic material of claim 61, wherein the oxidizing agent is peracetic acid.
63. The plastic material of claim 61, wherein the oxidizing agent is hydrogen peroxide.
64. The plastic material of claim 61, wherein the oxidizing agent is sodium chlorite.
65. The plastic material of claim 61, wherein the oxidizing agent is sodium hypochlorite.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161566520P | 2011-12-02 | 2011-12-02 | |
US61/566,520 | 2011-12-02 | ||
PCT/NZ2012/000224 WO2013081479A1 (en) | 2011-12-02 | 2012-11-30 | Methods of manufacturing plastic materials from decolorized blood protein |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ623962A NZ623962A (en) | 2015-06-26 |
NZ623962B2 true NZ623962B2 (en) | 2015-09-29 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007322460B2 (en) | Plastics material | |
Lagrain et al. | Molecular basis of processing wheat gluten toward biobased materials | |
Félix et al. | Development of rice protein bio-based plastic materials processed by injection molding | |
Shi et al. | Bio-based films from zein, keratin, pea, and rapeseed protein feedstocks | |
Poole et al. | Environmentally sustainable fibers from regenerated protein | |
Vineis et al. | Extraction and characterization of keratin from different biomasses | |
Verbeek et al. | Recent developments in thermo-mechanical processing of proteinous bioplastics | |
MXPA04000351A (en) | Keratin-based products and methods for their productions. | |
Garrido et al. | A more efficient process to develop protein films derived from agro-industrial by-products | |
Félix et al. | Development of crayfish protein-PCL biocomposite material processed by injection moulding | |
US20130139725A1 (en) | Methods of manufacturing plastic materials from decolorized blood protein | |
Rajabinejad et al. | PRACTICAL WAYS OF EXTRACTING KERATIN FROM KERATINOUS WASTES AND BY-PRODUCTS: A REVIEW. | |
Álvarez-Castillo et al. | Protein-based bioplastics from biowastes: sources, processing, properties and applications | |
Verbeek et al. | Processability and mechanical properties of bioplastics produced from decoloured bloodmeal | |
JP2012526845A (en) | Biopolymer material | |
Vicente et al. | Protein-based resins for food packaging | |
Mekonnen et al. | Processing, performance, and applications of plant and animal protein-based blends and their biocomposites | |
Zhang et al. | Proteins as sources of materials | |
Ghaffari-Bohlouli et al. | Protein by-products: Composition, extraction, and biomedical applications | |
NZ623962B2 (en) | Methods of manufacturing plastic materials from decolorized blood protein | |
Li et al. | Unveiling the reinforcement effects in cottonseed protein/polycaprolactone blend biocomposites | |
DE10054516A1 (en) | Extruded protein hydrolyzate, process for its preparation and its use | |
Low | Decoloured bloodmeal based bioplastic | |
Suratkar | Hydrolysed protein as a renewable plasticiser for renewable materials | |
van den Berg | Development of 2nd generation proteinous bioplastics |